data_2kly_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kly _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.61 0.243 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.551 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.647 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 9.0 t30 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.647 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.691 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HG3' HG12 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.532 HG23 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 47' ' ' THR . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.423 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HB3' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.466 ' CG ' ' H ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.466 ' H ' ' CG ' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 93' ' ' LEU . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.644 HG12 ' NE2' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.42 ' HB2' HG13 ' A' ' 90' ' ' ILE . 15.5 mt . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.924 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.644 ' NE2' HG12 ' A' ' 92' ' ' ILE . 47.6 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.499 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo . . . . . 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.499 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.609 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.1 OUTLIER -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.632 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 115' ' ' SER . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.539 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.463 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.442 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 63' ' ' ASP . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.478 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.445 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 119' ' ' ILE . 89.9 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.48 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.808 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 27.0 mm-40 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.808 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 116' ' ' VAL . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.403 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' PRO . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.599 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.616 ' HH2' ' HH ' ' A' ' 152' ' ' TYR . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.795 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.616 ' HH ' ' HH2' ' A' ' 144' ' ' TRP . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.795 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.437 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 2.9 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.536 ' HB2' HD11 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.487 ' O ' HD12 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.664 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' HG22 ' A' ' 47' ' ' THR . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' HB3' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.664 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.642 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.607 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.715 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.704 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.562 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.69 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.47 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.573 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG21 ' A' ' 123' ' ' VAL . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.229 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.607 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.629 ' HE3' ' HA ' ' A' ' 151' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.488 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.629 ' HA ' ' HE3' ' A' ' 143' ' ' MET . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.574 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 154' ' ' ILE . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.51 HG11 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 17.6 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.623 ' HA ' HD21 ' A' ' 165' ' ' LEU . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 161' ' ' LYS . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.658 0.266 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.401 HD21 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.574 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.624 HG22 HD21 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 8.6 t30 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 HD13 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.606 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.606 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB2' ' HG ' ' A' ' 67' ' ' SER . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.58 ' HG ' ' HB2' ' A' ' 63' ' ' ASP . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.424 ' HA ' HD13 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.581 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.445 ' HA ' HD22 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 119' ' ' ILE . 18.0 mt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.482 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.521 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HG2' ' OE1' ' A' ' 114' ' ' GLN . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.502 ' HA ' ' CG2' ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.515 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.586 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.56 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 17.2 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 12.6 mm-40 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.8 t30 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HG2' ' HG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.555 ' HG1' ' HG2' ' A' ' 44' ' ' PRO . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.619 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 123' ' ' VAL . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.69 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.737 ' HD1' HG13 ' A' ' 82' ' ' ILE . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.737 HG13 ' HD1' ' A' ' 79' ' ' HIS . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.586 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.453 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.475 ' OE1' ' HD3' ' A' ' 118' ' ' LYS . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.475 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.626 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.51 ' HE2' HG11 ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.526 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 6.5 mm100 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 165' ' ' LEU . 15.6 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 35' ' ' PHE . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.541 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.458 HD22 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' OE2' HG21 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.416 HD21 ' HG3' ' A' ' 32' ' ' GLU . 2.5 p-10 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.564 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.628 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CE1' HD22 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.678 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.678 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 65' ' ' PRO . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 71' ' ' MET . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' HD1' ' A' ' 79' ' ' HIS . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.674 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 92' ' ' ILE . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 92' ' ' ILE . 96.6 mt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.609 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.462 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.448 HG21 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HD22 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.412 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.513 ' HE1' HG13 ' A' ' 123' ' ' VAL . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.518 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo . . . . . 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.533 ' HE3' HD13 ' A' ' 154' ' ' ILE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.475 ' CB ' HD13 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.475 HD13 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.556 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.76 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.584 HG23 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.735 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.76 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.735 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.524 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB3' ' HE2' ' A' ' 126' ' ' MET . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.471 HG13 ' HD1' ' A' ' 79' ' ' HIS . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.441 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' LEU . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.412 HD22 ' HD2' ' A' ' 69' ' ' PRO . 7.4 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 1.067 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.627 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 1.067 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.513 HG11 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.549 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.601 ' HB1' ' CB ' ' A' ' 44' ' ' PRO . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 120.103 -0.276 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.459 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.487 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.414 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.487 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.525 ' CG2' ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.882 ' HB3' HD11 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.845 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.587 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.445 HD21 ' HG2' ' A' ' 36' ' ' GLU . 6.7 t30 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' HG11 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.675 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.845 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.675 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.813 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.797 ' HZ1' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.434 ' HA ' HG23 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.67 ' HD1' HG13 ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.67 HG13 ' HD1' ' A' ' 79' ' ' HIS . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.656 HG11 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.656 HG13 HG11 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.51 ' CZ3' HD13 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.529 ' HB2' HG13 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.482 ' C ' ' HG ' ' A' ' 115' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.482 ' HG ' ' C ' ' A' ' 114' ' ' GLN . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.51 HD13 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.649 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 127' ' ' LEU . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.532 ' HA ' HG23 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.621 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.621 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 3.6 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.665 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.789 ' HB3' HE21 ' A' ' 15' ' ' GLN . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.789 HE21 ' HB3' ' A' ' 14' ' ' LYS . 12.8 mm-40 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HB3' HD23 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.451 ' O ' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HE2' HD23 ' A' ' 40' ' ' LEU . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.692 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.499 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.692 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.701 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.464 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.652 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.751 0.31 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.566 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.606 ' HB3' HD12 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.532 ' O ' HG21 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 126' ' ' MET . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.514 ' HE1' HG13 ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.575 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.595 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.419 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.615 ' HZ2' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.609 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.562 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.3 OUTLIER -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.512 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.512 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.466 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.7 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HB2' HG22 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 128' ' ' ALA . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.515 ' CA ' HG11 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.7 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.64 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.412 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.412 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.613 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.447 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.609 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.467 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.567 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.609 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.476 HD21 HD11 ' A' ' 119' ' ' ILE . 16.6 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 92' ' ' ILE . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.364 -0.294 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.494 ' HE1' HD13 ' A' ' 154' ' ' ILE . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.424 ' CA ' HE21 ' A' ' 150' ' ' GLN . 0.0 OUTLIER -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.417 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.524 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.618 ' HZ1' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.494 HD13 ' HE1' ' A' ' 143' ' ' MET . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.515 HG11 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 70.0 mtm . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.67 -168.8 1.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.48 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.551 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.647 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 9.0 t30 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.647 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.691 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HG3' HG12 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.532 HG23 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 47' ' ' THR . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HB3' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.466 ' CG ' ' H ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.466 ' H ' ' CG ' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.507 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 131' ' ' ASN . 1.9 t-20 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 93' ' ' LEU . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.604 ' HB3' ' HG3' ' A' ' 133' ' ' GLU . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.644 HG12 ' NE2' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.42 ' HB2' HG13 ' A' ' 90' ' ' ILE . 15.5 mt -87.91 12.35 13.41 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.487 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.6 m80 -103.54 153.03 21.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.501 0.667 . . . . 0.0 110.946 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.4 143.24 36.2 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.568 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 110' ' ' TRP . 31.6 Cg_exo -62.05 105.45 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.584 2.189 . . . . 0.0 110.983 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.47 -26.0 7.12 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -89.47 64.3 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.22 91.32 19.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -89.36 -163.09 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.092 2.528 . . . . 0.0 113.652 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.4 mtp 68.34 -69.42 0.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.983 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.74 -36.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.479 -1.343 . . . . 0.0 114.545 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -68.83 168.7 12.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.343 0.592 . . . . 0.0 112.121 -171.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.17 159.98 15.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.315 -169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 m -79.24 14.9 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -76.5 -15.99 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.083 0.468 . . . . 0.0 110.078 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.54 171.29 14.54 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.65 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.65 136.99 47.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.089 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' HIS . 1.0 OUTLIER -144.08 -178.22 5.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.798 -175.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.924 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.924 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.644 ' NE2' HG12 ' A' ' 92' ' ' ILE . 47.6 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.499 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo -52.64 112.43 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 44.4 t30 -108.33 123.48 48.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.955 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -95.27 54.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.57 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' HG3' ' HB3' ' A' ' 91' ' ' SER . 0.3 OUTLIER -68.89 120.13 14.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.298 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t 72.33 -55.84 0.66 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.979 0.799 . . . . 0.0 110.382 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.48 1.43 Allowed Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.499 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.515 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.609 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.1 OUTLIER -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.91 0.386 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.57 -22.91 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.112 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.632 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 115' ' ' SER . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.539 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.463 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.442 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 63' ' ' ASP . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.478 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.632 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.467 ' HG3' HG22 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.445 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 119' ' ' ILE . 89.9 mt -89.43 -3.96 58.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -84.77 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.552 ' O ' ' HD2' ' A' ' 109' ' ' ARG . . . -154.79 138.14 10.69 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HB3' ' HB3' ' A' ' 110' ' ' TRP . 79.0 Cg_endo -78.52 2.78 7.8 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.551 2.168 . . . . 0.0 114.199 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.52 42.4 0.11 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.136 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.2 -160.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.749 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.869 ' HB2' HH22 ' A' ' 109' ' ' ARG . 47.0 m-20 63.77 86.33 0.15 Allowed Pre-proline 0 C--O 1.234 0.276 0 O-C-N 124.038 0.836 . . . . 0.0 112.632 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.2 70.92 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.248 1.965 . . . . 0.0 110.608 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.46 ' HG3' ' HB3' ' A' ' 99' ' ' ASP . 55.2 mtt -84.87 -24.14 28.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.15 -174.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.79 77.58 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.243 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -71.03 150.99 45.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 111.454 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -123.24 -166.61 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.482 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.4 t 73.99 -67.58 0.25 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.694 0.621 . . . . 0.0 110.857 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -150.98 123.13 8.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.65 45.94 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.18 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.1 168.55 18.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.869 HH22 ' HB2' ' A' ' 99' ' ' ASP . 16.1 mmt180 -128.89 161.83 28.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.705 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.808 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 27.0 mm-40 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' HA ' HD11 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.808 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 116' ' ' VAL . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.403 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.28 -0.71 5.29 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.562 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 7.7 t30 -30.96 -64.43 0.14 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.127 0.571 . . . . 0.0 112.494 172.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 75.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.338 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 131' ' ' ASN . 46.7 mt-10 -80.45 -34.47 35.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.9 t 72.9 -28.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.949 0.899 . . . . 0.0 112.221 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 133' ' ' GLU . . . 93.08 42.99 4.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.647 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' PRO . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.599 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.616 ' HH2' ' HH ' ' A' ' 152' ' ' TYR . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.795 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.616 ' HH ' ' HH2' ' A' ' 144' ' ' TRP . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.795 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.437 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 2.9 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.536 ' HB2' HD11 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.899 0.38 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.24 -165.76 2.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.642 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.513 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' O ' HD12 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.664 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HB2' HG22 ' A' ' 47' ' ' THR . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' HA2' HG11 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' HB3' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.664 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.642 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.607 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 134' ' ' SER . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.715 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.715 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.704 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.441 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.562 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 34.7 mt -87.07 15.03 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.87 ' HB3' ' HA ' ' A' ' 104' ' ' GLU . 13.5 m170 99.78 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.757 1.223 . . . . 0.0 110.467 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' N ' ' HD3' ' A' ' 96' ' ' PRO . . . -165.74 56.62 0.43 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.521 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.637 ' HB3' ' HD2' ' A' ' 109' ' ' ARG . 83.2 Cg_endo -93.31 -153.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.338 2.025 . . . . 0.0 111.275 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.53 47.6 1.45 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.24 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.595 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 24.6 t70 -99.79 34.81 2.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 0.0 109.693 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.74 98.96 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.635 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 101' ' ' MET . 83.1 Cg_exo -44.81 141.71 5.68 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.553 2.836 . . . . 0.0 113.219 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 22.9 mmt 73.14 -45.68 0.63 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.592 0.757 . . . . 0.0 111.911 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.62 -1.39 76.92 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 170.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' C ' ' HD1' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -70.32 -170.48 0.38 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.693 -0.753 . . . . 0.0 110.769 178.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.87 ' HA ' ' HB3' ' A' ' 94' ' ' HIS . 0.8 OUTLIER 67.12 179.18 0.22 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.415 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 38.6 t 68.25 -76.54 0.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.753 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 p -106.86 12.56 28.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.679 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.81 118.63 19.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.882 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 112.15 9.58 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.69 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? -160.24 -65.9 0.07 Allowed 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.47 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.745 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.573 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG21 ' A' ' 123' ' ' VAL . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.461 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -53.58 108.89 0.31 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.6 ' CG ' ' H ' ' A' ' 132' ' ' ASP . 10.9 t-20 -171.31 -162.99 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.856 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.6 ' H ' ' CG ' ' A' ' 131' ' ' ASN . 16.9 t70 82.75 -16.03 0.62 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -169.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 131' ' ' ASN . 15.6 tt0 56.96 -99.37 0.1 Allowed 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.397 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.458 ' HB2' ' OD1' ' A' ' 81' ' ' ASN . 66.5 m 49.17 86.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -75.64 50.96 2.59 Favored Glycine 0 C--O 1.228 -0.229 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.966 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.607 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.629 ' HE3' ' HA ' ' A' ' 151' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.488 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.629 ' HA ' ' HE3' ' A' ' 143' ' ' MET . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.574 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 154' ' ' ILE . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.51 HG11 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 17.6 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.623 ' HA ' HD21 ' A' ' 165' ' ' LEU . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 161' ' ' LYS . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.16 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.172 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.699 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD21 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.574 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.624 HG22 HD21 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 8.6 t30 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.552 ' CG2' ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 HD13 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.606 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB2' ' HG ' ' A' ' 67' ' ' SER . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.58 ' HG ' ' HB2' ' A' ' 63' ' ' ASP . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.424 ' HA ' HD13 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.581 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.445 ' HA ' HD22 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 94' ' ' HIS . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.445 HD23 HD12 ' A' ' 119' ' ' ILE . 18.0 mt -84.79 4.26 33.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 91' ' ' SER . 12.8 m170 -120.84 -178.41 3.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.785 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 109' ' ' ARG . . . -153.6 164.44 20.56 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.13 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.993 ' HD3' ' HG2' ' A' ' 109' ' ' ARG . 85.6 Cg_exo -49.27 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.088 2.525 . . . . 0.0 113.287 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.69 -37.73 1.87 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.063 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.7 43.95 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.951 0.882 . . . . 0.0 109.441 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.43 125.98 39.18 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.936 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.35 23.18 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.663 2.242 . . . . 0.0 112.956 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG3' ' HA3' ' A' ' 135' ' ' GLY . 7.9 mmt -153.13 -30.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.81 27.02 57.54 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.222 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 91' ' ' SER . 14.6 p90 -72.69 -161.39 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.432 0.693 . . . . 0.0 111.593 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -53.97 118.84 4.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 111.177 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 t -83.47 -14.74 51.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.013 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 m -99.44 16.76 22.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.69 46.58 0.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.301 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' C ' ' HD2' ' A' ' 109' ' ' ARG . 13.7 mm-40 64.55 117.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.615 0.721 . . . . 0.0 112.124 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.993 ' HG2' ' HD3' ' A' ' 96' ' ' PRO . 2.3 mpt_? -122.67 176.01 6.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.482 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.521 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HG2' ' OE1' ' A' ' 114' ' ' GLN . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.502 ' HA ' ' CG2' ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.515 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo -51.45 131.31 36.19 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.58 118.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.706 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -144.54 -71.21 0.28 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.682 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -86.16 -60.75 1.92 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.892 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.474 ' H ' ' CD ' ' A' ' 133' ' ' GLU . 32.2 t -71.23 -170.77 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.823 0.82 . . . . 0.0 112.462 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.447 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -177.55 35.48 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -174.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.586 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.56 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.437 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 17.2 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.67 19.91 10.88 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.767 0.667 . . . . 0.0 112.037 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 12.6 mm-40 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.527 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.524 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.8 t30 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HG2' ' HG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.555 ' HG1' ' HG2' ' A' ' 44' ' ' PRO . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.619 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 123' ' ' VAL . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.69 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.737 ' HD1' HG13 ' A' ' 82' ' ' ILE . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.737 HG13 ' HD1' ' A' ' 79' ' ' HIS . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' O ' HG21 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.586 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.47 -1.05 56.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 16.6 t-160 -86.09 -80.66 0.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -164.22 150.61 9.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.521 0.201 . . . . 0.0 110.995 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.57 -20.31 20.63 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.963 2.442 . . . . 0.0 111.502 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -129.22 63.9 0.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.79 31.56 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 71.16 143.31 0.1 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 O-C-N 123.905 0.753 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.41 72.69 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.91 2.407 . . . . 0.0 112.107 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.4 mmm -83.86 -6.47 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.543 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.3 41.85 9.0 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.346 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.883 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -68.55 142.74 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.137 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -137.09 -175.63 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.651 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m 62.28 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.74 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.48 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 27.2 m -85.0 -63.77 1.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.12 47.08 24.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.315 0.578 . . . . 0.0 110.678 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' HG2' ' HB3' ' A' ' 106' ' ' SER . 6.3 mm-40 -73.17 140.24 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.043 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? -117.43 147.01 43.09 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.453 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.475 ' OE1' ' HD3' ' A' ' 118' ' ' LYS . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.475 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.626 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.51 ' HE2' HG11 ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.05 -174.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.606 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . 6.5 m120 -104.71 95.45 5.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.907 0.86 . . . . 0.0 111.808 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.49 56.98 3.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.934 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.883 ' HG3' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -161.65 -46.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.004 0.43 . . . . 0.0 110.393 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 p -80.85 -85.45 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.336 0.589 . . . . 0.0 111.584 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 65.03 1.41 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.564 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.526 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 6.5 mm100 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 165' ' ' LEU . 15.6 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HE3' HD13 ' A' ' 62' ' ' LEU . 25.5 ptt? . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.625 0.25 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 35' ' ' PHE . . . -130.94 18.58 5.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.541 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.458 HD22 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' OE2' HG21 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.55 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.416 HD21 ' HG3' ' A' ' 32' ' ' GLU . 2.5 p-10 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.564 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.628 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CE1' HD22 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.678 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.678 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 65' ' ' PRO . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.541 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 71' ' ' MET . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.412 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 132' ' ' ASP . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' HD1' ' A' ' 79' ' ' HIS . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.533 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.674 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 HG21 HG22 ' A' ' 92' ' ' ILE . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 92' ' ' ILE . 96.6 mt -92.42 4.53 53.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -100.27 -66.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 98' ' ' ASP . . . -163.91 138.09 4.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 11.5 Cg_exo -71.34 -33.87 10.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.852 2.368 . . . . 0.0 111.835 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.38 65.73 0.47 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 16.6 t70 -85.9 154.69 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.91 126.3 88.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.108 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.23 95.51 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.688 2.259 . . . . 0.0 111.849 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -79.39 -44.01 22.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.973 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -159.36 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.236 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -77.45 12.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 68.19 -171.39 0.19 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.573 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.54 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 8.7 t -84.53 7.22 20.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.134 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 19.8 m -67.21 174.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.028 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 106' ' ' SER . . . 75.72 166.79 0.27 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.301 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.66 150.25 36.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.32 0.581 . . . . 0.0 111.313 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.565 ' HB3' ' HA ' ' A' ' 96' ' ' PRO . 72.0 mmt-85 -121.09 150.07 41.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.609 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.462 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.448 HG21 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' HD22 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.412 ' O ' HG22 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.499 HG12 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.513 ' HE1' HG13 ' A' ' 123' ' ' VAL . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.518 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo -43.62 -30.09 2.56 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -104.94 78.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.297 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 126' ' ' MET . 38.6 t70 -65.53 -49.12 70.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.433 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.68 ' HG3' ' H ' ' A' ' 134' ' ' SER . 3.6 pt-20 -164.22 -63.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.68 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 88.3 p -80.34 155.71 27.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -169.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -106.88 52.54 0.66 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.533 ' HE3' HD13 ' A' ' 154' ' ' ILE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.549 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.425 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.475 ' CB ' HD13 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.475 HD13 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 -160.47 0.31 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.483 0.489 . . . . 0.0 111.04 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.755 HG22 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.755 ' HE2' HG22 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.76 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.501 HD11 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.584 HG23 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.523 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.735 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.76 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.735 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.524 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' HB3' ' HE2' ' A' ' 126' ' ' MET . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.471 HG13 ' HD1' ' A' ' 79' ' ' HIS . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.441 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' LEU . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.412 HD22 ' HD2' ' A' ' 69' ' ' PRO . 7.4 mt -151.59 20.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -112.05 -63.24 1.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 1.003 ' HB1' ' HB2' ' A' ' 98' ' ' ASP . . . -163.18 141.59 6.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.518 ' HA ' ' HD2' ' A' ' 109' ' ' ARG . 7.1 Cg_exo -74.55 -2.92 13.07 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.266 2.644 . . . . 0.0 111.678 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.4 2.01 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 1.003 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 33.4 t70 -91.06 150.8 21.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.56 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -104.71 116.27 61.25 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.525 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.53 124.44 12.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.383 2.722 . . . . 0.0 112.92 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 64.4 mtm -76.54 -43.2 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.96 14.84 0.42 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.505 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.68 154.51 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.316 0.579 . . . . 0.0 112.251 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -143.69 146.85 33.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.294 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.6 t 66.72 -75.8 0.05 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.843 0.715 . . . . 0.0 110.99 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.2 m -71.35 93.94 1.18 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.421 0.629 . . . . 0.0 109.983 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.61 30.77 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.851 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.86 167.99 19.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.371 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 96' ' ' PRO . 12.9 mmt180 -80.57 160.85 25.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.489 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 1.067 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.627 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 1.067 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.513 HG11 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.549 ' HE2' ' HB3' ' A' ' 81' ' ' ASN . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.601 ' HB1' ' CB ' ' A' ' 44' ' ' PRO . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 131' ' ' ASN . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.48 36.02 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 129' ' ' GLU . 1.9 p-10 -132.0 49.27 2.33 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.9 m-20 -79.92 -5.13 55.03 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 132' ' ' ASP . 23.3 mm-40 74.51 176.02 0.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.504 -171.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 73.68 144.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.219 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.35 75.77 0.4 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.418 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.459 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.487 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.414 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.487 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.525 ' CG2' ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.882 ' HB3' HD11 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -77.44 -36.29 53.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.845 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.587 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.445 HD21 ' HG2' ' A' ' 36' ' ' GLU . 6.7 t30 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.532 HG23 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA2' HG11 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.675 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.845 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.675 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.813 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.797 ' HZ1' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.529 ' O ' HG22 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.434 ' HA ' HG23 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' HD1' HG13 ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.67 HG13 ' HD1' ' A' ' 79' ' ' HIS . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.656 HG11 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.656 HG13 HG11 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.98 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.13 9.01 7.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' H ' ' C ' ' A' ' 92' ' ' ILE . 73.3 m80 -143.39 -149.59 0.28 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.297 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 98' ' ' ASP . . . 57.96 55.28 6.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 98' ' ' ASP . 74.4 Cg_endo -88.66 49.93 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.407 2.071 . . . . 0.0 110.782 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.63 3.02 69.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -169.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.77 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 9.7 t70 -115.49 105.61 13.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.332 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -81.67 120.54 78.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.328 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -91.22 115.78 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.044 2.496 . . . . 0.0 113.093 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.56 -172.09 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.352 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.87 43.25 3.15 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.155 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -72.94 146.3 46.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.83 0.348 . . . . 0.0 110.157 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.21 18.38 1.38 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.988 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 107' ' ' ALA . 72.2 m -80.88 51.55 1.56 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.66 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m 74.12 -23.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.462 0.705 . . . . 0.0 112.132 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 105' ' ' SER . . . 52.64 74.49 0.28 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 111.111 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.98 ' HG2' ' HB ' ' A' ' 92' ' ' ILE . 1.8 pm0 -72.31 160.62 32.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.856 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 95' ' ' ALA . 28.2 tpt180 -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.095 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.51 ' CZ3' HD13 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.529 ' HB2' HG13 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.482 ' C ' ' HG ' ' A' ' 115' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.482 ' HG ' ' C ' ' A' ' 114' ' ' GLN . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.51 HD13 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.649 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 127' ' ' LEU . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.532 ' HA ' HG23 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.621 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo -66.01 170.22 12.06 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.17 168.16 28.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.74 ' HA ' ' HB3' ' A' ' 141' ' ' SER . 3.3 p30 -67.67 -8.63 36.51 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.34 114.6 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.8 p -168.19 122.74 0.94 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.569 0.699 . . . . 0.0 112.299 -168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.74 13.16 32.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.982 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.74 ' HB3' ' HA ' ' A' ' 132' ' ' ASP . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.621 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.575 ' HD3' ' HB3' ' A' ' 132' ' ' ASP . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.5 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 3.6 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.554 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 63.5 mtt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -151.39 -54.96 0.14 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.665 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.789 ' HB3' HE21 ' A' ' 15' ' ' GLN . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.789 HE21 ' HB3' ' A' ' 14' ' ' LYS . 12.8 mm-40 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.478 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HB3' HD23 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.451 ' O ' HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HE2' HD23 ' A' ' 40' ' ' LEU . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.692 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.499 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.692 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.701 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 1' ' ' MET . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.665 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.464 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.652 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.53 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.52 ' HA ' ' HE1' ' A' ' 94' ' ' HIS . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt -80.69 3.94 20.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.771 ' HB3' HH21 ' A' ' 109' ' ' ARG . 64.6 m80 -119.61 165.42 14.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.252 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -150.7 168.51 10.88 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.19 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 35.1 Cg_endo -65.51 53.55 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.905 2.404 . . . . 0.0 112.372 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -155.44 20.95 0.55 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -113.93 175.07 5.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 26.1 t70 -93.23 123.97 59.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 24.6 Cg_exo -64.53 83.14 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.956 2.438 . . . . 0.0 112.157 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.1 mtm -79.88 -40.92 27.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.023 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -156.2 1.75 0.15 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.361 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.35 -167.42 1.19 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.335 0.254 . . . . 0.0 110.878 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.2 60.26 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.09 0.948 . . . . 0.0 109.497 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 t -154.64 49.48 0.6 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.553 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m 67.94 77.29 0.25 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.838 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.92 121.29 3.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.132 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.84 150.08 39.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.771 HH21 ' HB3' ' A' ' 94' ' ' HIS . 32.2 mmm-85 -117.45 178.17 4.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.566 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.606 ' HB3' HD12 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.532 ' O ' HG21 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 126' ' ' MET . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.514 ' HE1' HG13 ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo -42.29 117.22 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 0.6 OUTLIER -78.53 -8.83 58.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -164.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' A' ' 131' ' ' ASN . 20.2 t70 79.4 -15.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.59 0.556 . . . . 0.0 111.293 173.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -76.64 74.39 3.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.493 ' HB3' ' ND2' ' A' ' 81' ' ' ASN . 25.4 p -176.21 174.03 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.71 57.63 0.28 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 166.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.575 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.595 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.419 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.615 ' HZ2' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.609 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.562 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.3 OUTLIER -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.476 0.179 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.88 -173.44 1.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.519 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.512 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.512 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.466 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.7 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.506 ' HB2' HG22 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 128' ' ' ALA . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.515 ' CA ' HG11 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.7 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 1' ' ' MET . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.652 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.433 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.64 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.412 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.412 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.613 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.447 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.609 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.467 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.567 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.609 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.811 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.476 HD21 HD11 ' A' ' 119' ' ' ILE . 16.6 mt -82.81 27.92 0.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 110' ' ' TRP . 46.4 t-80 102.62 87.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.873 1.358 . . . . 0.0 111.001 165.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 91' ' ' SER . . . -150.9 56.41 2.05 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.057 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 95' ' ' ALA . 6.3 Cg_exo -79.54 -60.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.507 2.138 . . . . 0.0 111.25 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.99 35.82 2.65 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.41 121.17 32.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.484 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 11.4 t70 69.98 138.8 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.112 0.883 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 17.1 Cg_exo -67.27 79.53 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.054 2.502 . . . . 0.0 112.94 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.779 ' HE3' ' HA3' ' A' ' 135' ' ' GLY . 65.3 mtm -148.42 -178.09 6.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.56 56.78 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.563 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.518 ' HE2' ' SD ' ' A' ' 101' ' ' MET . 65.9 m-85 -71.22 153.4 42.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.419 . . . . 0.0 111.383 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.01 115.08 0.97 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.743 171.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 t -156.27 67.91 0.6 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t 68.77 27.71 5.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.899 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.73 103.92 7.96 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.41 166.82 22.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.216 0.531 . . . . 0.0 111.039 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -118.51 153.51 34.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.817 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.64 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.682 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 92' ' ' ILE . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.517 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo -52.92 107.15 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.7 169.71 17.11 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.494 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 55.96 61.15 2.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.236 0.96 . . . . 0.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -74.34 68.16 1.49 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.484 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 78.9 p -63.51 -7.33 6.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.779 ' HA3' ' HE3' ' A' ' 101' ' ' MET . . . 99.22 48.73 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.364 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.494 ' HE1' HD13 ' A' ' 154' ' ' ILE . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.424 ' CA ' HE21 ' A' ' 150' ' ' GLN . 0.0 OUTLIER -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.417 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.524 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.618 ' HZ1' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.494 HD13 ' HE1' ' A' ' 143' ' ' MET . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.515 HG11 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.61 0.243 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.657 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.714 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.549 HG21 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.501 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.9 t-20 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 88' ' ' VAL . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.511 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 93' ' ' LEU . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.508 HG12 ' OE1' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.44 ' H ' HG13 ' A' ' 90' ' ' ILE . 15.5 mt . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.709 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.932 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.508 ' OE1' HG12 ' A' ' 92' ' ' ILE . 14.7 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo . . . . . 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.494 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.51 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 3.6 pt20 -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.571 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.458 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.645 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.442 HD21 HG23 ' A' ' 90' ' ' ILE . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 119' ' ' ILE . 89.9 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.813 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 14.3 mm100 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 93' ' ' LEU . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.416 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 126' ' ' MET . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.821 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 148' ' ' ARG . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.821 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 19.6 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' HD21 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HZ3' HD12 ' A' ' 16' ' ' LEU . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.705 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.688 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.668 HG21 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.705 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' HE2' ' HE2' ' A' ' 143' ' ' MET . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.476 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.757 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 12' ' ' GLU . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.757 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.456 HD11 ' HZ3' ' A' ' 110' ' ' TRP . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.229 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.63 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.525 ' HE2' ' HE2' ' A' ' 78' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 5.4 mm-40 -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 48' ' ' CYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.627 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 161' ' ' LYS . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.53 HG13 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 65.1 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.627 ' HE2' ' HG2' ' A' ' 157' ' ' GLN . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 51' ' ' PHE . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.658 0.266 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.654 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 HG23 HD23 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.782 ' HB2' HG21 ' A' ' 47' ' ' THR . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.603 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HD12 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.508 HD21 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' HA ' HD21 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 119' ' ' ILE . 18.0 mt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.3 mpt_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.409 ' HG2' HD23 ' A' ' 121' ' ' LEU . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 115' ' ' SER . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD23 ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.602 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 82.7 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 6.6 mm100 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.535 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 2.4 t-20 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' PHE . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.691 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 82' ' ' ILE . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.523 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.799 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.549 HG12 HG12 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.599 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.508 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 24' ' ' ILE . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.522 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.799 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.535 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 40.3 mm-40 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.662 ' HB3' HD12 ' A' ' 165' ' ' LEU . 56.1 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB1' ' HZ ' ' A' ' 35' ' ' PHE . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' OE2' HG22 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' HZ ' ' HB1' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.588 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HG3' HG13 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.47 ' CE1' HD21 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.643 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE2' ' HE1' ' A' ' 143' ' ' MET . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 83' ' ' TYR . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.544 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.677 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 92' ' ' ILE . 96.6 mt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.46 HG22 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.786 ' HA ' ' HE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo . . . . . 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 2.8 pt20 -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.481 ' CB ' HD12 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.787 ' HE2' HG23 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.461 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.568 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.643 HG21 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.569 ' HB2' HG11 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.769 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.758 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 72' ' ' ARG . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.559 ' HA ' HG21 ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.528 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 93' ' ' LEU . 7.4 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.48 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 1.03 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 1.03 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.478 HG22 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.643 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 120.103 -0.276 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.447 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.429 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.447 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 51' ' ' PHE . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.9 ' HB3' HD12 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.9 HD12 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.601 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.471 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 35' ' ' PHE . 27.5 t-20 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.858 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.688 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.83 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG21 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.662 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.672 HG13 HG12 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.528 ' CZ3' HD11 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.47 ' HB3' ' OE2' ' A' ' 12' ' ' GLU . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 115' ' ' SER . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.528 HD11 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HB3' HG12 ' A' ' 24' ' ' ILE . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 80' ' ' PRO . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.626 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 144' ' ' TRP . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 23.9 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 5.9 mm100 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.448 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.64 ' HB3' HD21 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB2' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ALA . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.772 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.667 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.662 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.47 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.658 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.751 0.31 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.619 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 4.5 pt20 -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 44' ' ' PRO . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.554 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.737 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.68 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.646 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.594 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.445 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.621 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.469 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.573 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.621 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 16.6 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.646 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.689 ' HB3' HD11 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 93' ' ' LEU . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.364 -0.294 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.413 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 77' ' ' MET . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 70.0 mtm . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.67 -168.8 1.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.48 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.657 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.714 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.549 HG21 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.501 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 131' ' ' ASN . 59.7 t30 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 88' ' ' VAL . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.511 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.694 ' O ' ' HD2' ' A' ' 94' ' ' HIS . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.604 ' HB3' ' HG3' ' A' ' 133' ' ' GLU . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.508 HG12 ' OE1' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.44 ' H ' HG13 ' A' ' 90' ' ' ILE . 15.5 mt -87.91 12.35 13.41 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.694 ' HD2' ' O ' ' A' ' 90' ' ' ILE . 1.9 m-70 -103.54 153.03 21.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.501 0.667 . . . . 0.0 110.946 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.4 143.24 36.2 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.568 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 110' ' ' TRP . 31.6 Cg_exo -62.05 105.45 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.584 2.189 . . . . 0.0 110.983 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.47 -26.0 7.12 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -89.47 64.3 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.22 91.32 19.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -89.36 -163.09 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.092 2.528 . . . . 0.0 113.652 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.4 mtp 68.34 -69.42 0.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.983 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.74 -36.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.479 -1.343 . . . . 0.0 114.545 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -68.83 168.7 12.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.343 0.592 . . . . 0.0 112.121 -171.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.17 159.98 15.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.315 -169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 m -79.24 14.9 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -76.5 -15.99 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.083 0.468 . . . . 0.0 110.078 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.54 171.29 14.54 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.65 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.65 136.99 47.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.089 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 94' ' ' HIS . 1.0 OUTLIER -144.08 -178.22 5.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.798 -175.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.709 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.932 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.508 ' OE1' HG12 ' A' ' 92' ' ' ILE . 14.7 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo -52.64 112.43 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 44.4 t30 -108.33 123.48 48.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.955 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -95.27 54.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.57 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' HG3' ' HB3' ' A' ' 91' ' ' SER . 0.3 OUTLIER -68.89 120.13 14.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.298 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t 72.33 -55.84 0.66 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.979 0.799 . . . . 0.0 110.382 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.48 1.43 Allowed Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.494 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.51 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 3.6 pt20 -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.91 0.386 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.57 -22.91 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.112 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.571 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.458 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.645 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.442 HD21 HG23 ' A' ' 90' ' ' ILE . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 119' ' ' ILE . 89.9 mt -89.43 -3.96 58.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -84.77 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 109' ' ' ARG . . . -154.79 138.14 10.69 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 110' ' ' TRP . 79.0 Cg_endo -78.52 2.78 7.8 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.551 2.168 . . . . 0.0 114.199 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.52 42.4 0.11 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.136 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.2 -160.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.749 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.901 ' HB2' HH22 ' A' ' 109' ' ' ARG . 47.0 m-20 63.77 86.33 0.15 Allowed Pre-proline 0 C--O 1.234 0.276 0 O-C-N 124.038 0.836 . . . . 0.0 112.632 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.2 70.92 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.248 1.965 . . . . 0.0 110.608 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 99' ' ' ASP . 55.2 mtt -84.87 -24.14 28.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.15 -174.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.79 77.58 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.243 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -71.03 150.99 45.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 111.454 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 105' ' ' SER . 22.1 pt-20 -123.24 -166.61 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.482 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 33.4 t 73.99 -67.58 0.25 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.694 0.621 . . . . 0.0 110.857 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -150.98 123.13 8.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.65 45.94 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.18 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 5.6 pt-20 -73.1 168.55 18.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.901 HH22 ' HB2' ' A' ' 99' ' ' ASP . 16.1 mmt180 -128.89 161.83 28.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.705 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.813 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 14.3 mm100 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 93' ' ' LEU . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.416 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 126' ' ' MET . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.28 -0.71 5.29 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.57 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 7.7 t30 -30.96 -64.43 0.14 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.127 0.571 . . . . 0.0 112.494 172.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 75.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.338 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 131' ' ' ASN . 46.7 mt-10 -80.45 -34.47 35.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.9 t 72.9 -28.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.949 0.899 . . . . 0.0 112.221 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.08 42.99 4.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.647 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.821 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 148' ' ' ARG . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.821 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 19.6 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.899 0.38 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.24 -165.76 2.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' HD21 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HZ3' HD12 ' A' ' 16' ' ' LEU . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.705 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.688 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.668 HG21 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.705 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' HE2' ' HE2' ' A' ' 143' ' ' MET . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 134' ' ' SER . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 34.7 mt -87.07 15.03 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' HB3' ' HA ' ' A' ' 104' ' ' GLU . 13.5 m170 99.78 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.757 1.223 . . . . 0.0 110.467 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 96' ' ' PRO . . . -165.74 56.62 0.43 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.521 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.661 ' HB3' ' HD2' ' A' ' 109' ' ' ARG . 83.2 Cg_endo -93.31 -153.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.338 2.025 . . . . 0.0 111.275 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.53 47.6 1.45 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.24 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 24.6 t70 -99.79 34.81 2.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 0.0 109.693 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.74 98.96 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.635 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' MET . 83.1 Cg_exo -44.81 141.71 5.68 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.553 2.836 . . . . 0.0 113.219 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 22.9 mmt 73.14 -45.68 0.63 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.592 0.757 . . . . 0.0 111.911 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.62 -1.39 76.92 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 170.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.457 ' C ' ' HD1' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -70.32 -170.48 0.38 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.693 -0.753 . . . . 0.0 110.769 178.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' A' ' 94' ' ' HIS . 0.8 OUTLIER 67.12 179.18 0.22 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.418 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 38.6 t 68.25 -76.54 0.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.753 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 p -106.86 12.56 28.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.679 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.81 118.63 19.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.882 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 112.15 9.58 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? -160.24 -65.9 0.07 Allowed 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.476 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.757 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 12' ' ' GLU . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.757 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.456 HD11 ' HZ3' ' A' ' 110' ' ' TRP . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -53.58 108.89 0.31 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.568 ' CG ' ' H ' ' A' ' 132' ' ' ASP . 10.9 t-20 -171.31 -162.99 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.856 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 131' ' ' ASN . 16.9 t70 82.75 -16.03 0.62 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -169.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 131' ' ' ASN . 15.6 tt0 56.96 -99.37 0.1 Allowed 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.397 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.479 ' HB2' ' OD1' ' A' ' 81' ' ' ASN . 66.5 m 49.17 86.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -75.64 50.96 2.59 Favored Glycine 0 C--O 1.228 -0.229 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.966 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.63 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.525 ' HE2' ' HE2' ' A' ' 78' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 5.4 mm-40 -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 48' ' ' CYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.627 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 161' ' ' LYS . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.53 HG13 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 65.1 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.627 ' HE2' ' HG2' ' A' ' 157' ' ' GLN . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 51' ' ' PHE . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.16 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.172 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.654 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 HG23 HD23 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.782 ' HB2' HG21 ' A' ' 47' ' ' THR . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.603 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HD12 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.508 HD21 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' HA ' HD21 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 94' ' ' HIS . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 119' ' ' ILE . 18.0 mt -84.79 4.26 33.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 91' ' ' SER . 12.8 m170 -120.84 -178.41 3.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.785 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' ARG . . . -153.6 164.44 20.56 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.13 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 1.005 ' HD3' ' HG2' ' A' ' 109' ' ' ARG . 85.6 Cg_exo -49.27 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.088 2.525 . . . . 0.0 113.287 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.69 -37.73 1.87 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.063 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.7 43.95 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.951 0.882 . . . . 0.0 109.441 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.43 125.98 39.18 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.936 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.35 23.18 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.663 2.242 . . . . 0.0 112.956 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.483 ' HG3' ' HA3' ' A' ' 135' ' ' GLY . 7.9 mmt -153.13 -30.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.81 27.02 57.54 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.222 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 91' ' ' SER . 14.6 p90 -72.69 -161.39 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.432 0.693 . . . . 0.0 111.593 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -53.97 118.84 4.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 111.177 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 t -83.47 -14.74 51.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.013 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 m -99.44 16.76 22.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.69 46.58 0.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.301 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' C ' ' HD2' ' A' ' 109' ' ' ARG . 13.7 mm-40 64.55 117.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.615 0.721 . . . . 0.0 112.124 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 1.005 ' HG2' ' HD3' ' A' ' 96' ' ' PRO . 2.3 mpt_? -122.67 176.01 6.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.409 ' HG2' HD23 ' A' ' 121' ' ' LEU . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 115' ' ' SER . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD23 ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo -51.45 131.31 36.19 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.58 118.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.706 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -144.54 -71.21 0.28 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.682 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -86.16 -60.75 1.92 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.892 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.465 ' H ' ' CD ' ' A' ' 133' ' ' GLU . 32.2 t -71.23 -170.77 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.823 0.82 . . . . 0.0 112.462 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -177.55 35.48 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -174.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.602 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 82.7 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.67 19.91 10.88 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.767 0.667 . . . . 0.0 112.037 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 6.6 mm100 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.535 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 2.4 t-20 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' PHE . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.691 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 82' ' ' ILE . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.523 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.799 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.549 HG12 HG12 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.599 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.47 -1.05 56.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 16.6 t-160 -86.09 -80.66 0.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -164.22 150.61 9.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.521 0.201 . . . . 0.0 110.995 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.57 -20.31 20.63 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.963 2.442 . . . . 0.0 111.502 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -129.22 63.9 0.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.79 31.56 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 71.16 143.31 0.1 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 O-C-N 123.905 0.753 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.41 72.69 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.91 2.407 . . . . 0.0 112.107 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.4 mmm -83.86 -6.47 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.543 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.3 41.85 9.0 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.346 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.906 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -68.55 142.74 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.137 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -137.09 -175.63 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.651 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m 62.28 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.74 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.518 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 27.2 m -85.0 -63.77 1.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.12 47.08 24.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.315 0.578 . . . . 0.0 110.678 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 106' ' ' SER . 6.3 mm-40 -73.17 140.24 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.043 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? -117.43 147.01 43.09 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.508 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 24' ' ' ILE . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.05 -174.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.598 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . 6.5 m120 -104.71 95.45 5.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.907 0.86 . . . . 0.0 111.808 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.49 56.98 3.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.934 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.906 ' HG3' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -161.65 -46.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.004 0.43 . . . . 0.0 110.393 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 p -80.85 -85.45 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.336 0.589 . . . . 0.0 111.584 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 65.03 1.41 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.564 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.522 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.799 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.535 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 40.3 mm-40 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.662 ' HB3' HD12 ' A' ' 165' ' ' LEU . 56.1 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.625 0.25 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB1' ' HZ ' ' A' ' 35' ' ' PHE . . . -130.94 18.58 5.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' OE2' HG22 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' HZ ' ' HB1' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.588 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HG3' HG13 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.47 ' CE1' HD21 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.643 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE2' ' HE1' ' A' ' 143' ' ' MET . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 132' ' ' ASP . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 83' ' ' TYR . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.544 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.677 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 92' ' ' ILE . 96.6 mt -92.42 4.53 53.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -100.27 -66.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 98' ' ' ASP . . . -163.91 138.09 4.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 11.5 Cg_exo -71.34 -33.87 10.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.852 2.368 . . . . 0.0 111.835 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.38 65.73 0.47 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 16.6 t70 -85.9 154.69 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 12.0 t70 -74.91 126.3 88.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.108 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 26.7 Cg_exo -62.23 95.51 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.688 2.259 . . . . 0.0 111.849 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -79.39 -44.01 22.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.973 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -159.36 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.236 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -77.45 12.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 68.19 -171.39 0.19 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.573 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.542 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 8.7 t -84.53 7.22 20.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.134 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 19.8 m -67.21 174.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.028 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 106' ' ' SER . . . 75.72 166.79 0.27 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.301 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.66 150.25 36.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.32 0.581 . . . . 0.0 111.313 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 96' ' ' PRO . 72.0 mmt-85 -121.09 150.07 41.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.46 HG22 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.495 ' CB ' ' HB2' ' A' ' 132' ' ' ASP . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.786 ' HA ' ' HE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo -43.62 -30.09 2.56 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -104.94 78.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.297 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 126' ' ' MET . 38.6 t70 -65.53 -49.12 70.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.433 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.736 ' HG3' ' H ' ' A' ' 134' ' ' SER . 3.6 pt-20 -164.22 -63.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.736 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 88.3 p -80.34 155.71 27.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -169.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -106.88 52.54 0.66 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 2.8 pt20 -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.481 ' CB ' HD12 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 -160.47 0.31 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.483 0.489 . . . . 0.0 111.04 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.787 ' HE2' HG23 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.461 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.568 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.643 HG21 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.569 ' HB2' HG11 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.769 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.758 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 72' ' ' ARG . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.559 ' HA ' HG21 ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.528 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 93' ' ' LEU . 7.4 mt -151.59 20.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -112.05 -63.24 1.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 98' ' ' ASP . . . -163.18 141.59 6.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HA ' ' HD2' ' A' ' 109' ' ' ARG . 7.1 Cg_exo -74.55 -2.92 13.07 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.266 2.644 . . . . 0.0 111.678 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.4 2.01 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 1.059 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 33.4 t70 -91.06 150.8 21.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.56 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -104.71 116.27 61.25 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.525 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.53 124.44 12.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.383 2.722 . . . . 0.0 112.92 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 64.4 mtm -76.54 -43.2 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.96 14.84 0.42 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.505 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.68 154.51 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.316 0.579 . . . . 0.0 112.251 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -143.69 146.85 33.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.294 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.6 t 66.72 -75.8 0.05 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.843 0.715 . . . . 0.0 110.99 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.2 m -71.35 93.94 1.18 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.421 0.629 . . . . 0.0 109.983 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.61 30.77 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.851 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.86 167.99 19.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.371 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.581 ' HD2' ' HA ' ' A' ' 96' ' ' PRO . 12.9 mmt180 -80.57 160.85 25.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.48 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 1.03 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 1.03 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.478 HG22 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.643 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.48 36.02 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -132.0 49.27 2.33 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.9 m-20 -79.92 -5.13 55.03 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 132' ' ' ASP . 23.3 mm-40 74.51 176.02 0.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.504 -171.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 73.68 144.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.219 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.35 75.77 0.4 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.418 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.447 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.429 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.447 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 51' ' ' PHE . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.9 ' HB3' HD12 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.9 HD12 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -77.44 -36.29 53.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.601 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.471 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 35' ' ' PHE . 27.5 t-20 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.858 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.688 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.83 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG21 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.662 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.672 HG13 HG12 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.997 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.13 9.01 7.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 73.3 m80 -143.39 -149.59 0.28 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.297 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ASP . . . 57.96 55.28 6.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HD2' ' HB3' ' A' ' 98' ' ' ASP . 74.4 Cg_endo -88.66 49.93 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.407 2.071 . . . . 0.0 110.782 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.63 3.02 69.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -169.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.8 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 9.7 t70 -115.49 105.61 13.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.332 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 9.0 p-10 -81.67 120.54 78.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.328 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 53.6 Cg_endo -91.22 115.78 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.044 2.496 . . . . 0.0 113.093 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.56 -172.09 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.352 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.87 43.25 3.15 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.155 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -72.94 146.3 46.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.83 0.348 . . . . 0.0 110.157 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.21 18.38 1.38 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.988 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.2 m -80.88 51.55 1.56 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.66 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m 74.12 -23.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.462 0.705 . . . . 0.0 112.132 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 52.64 74.49 0.28 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 111.111 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.997 ' HG2' ' HB ' ' A' ' 92' ' ' ILE . 1.8 pm0 -72.31 160.62 32.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.856 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 95' ' ' ALA . 28.2 tpt180 -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.095 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.528 ' CZ3' HD11 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.47 ' HB3' ' OE2' ' A' ' 12' ' ' GLU . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 115' ' ' SER . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.528 HD11 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HB3' HG12 ' A' ' 24' ' ' ILE . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo -66.01 170.22 12.06 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.17 168.16 28.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.763 ' HA ' ' HB3' ' A' ' 141' ' ' SER . 3.3 p30 -67.67 -8.63 36.51 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.34 114.6 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.8 p -168.19 122.74 0.94 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.569 0.699 . . . . 0.0 112.299 -168.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.74 13.16 32.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.982 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 80' ' ' PRO . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.763 ' HB3' ' HA ' ' A' ' 132' ' ' ASP . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.626 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD3' ' HB3' ' A' ' 132' ' ' ASP . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 144' ' ' TRP . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 23.9 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 63.5 mtt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -151.39 -54.96 0.14 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 5.9 mm100 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.448 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.64 ' HB3' HD21 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB2' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ALA . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.772 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 1' ' ' MET . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.667 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.662 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.47 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.658 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.545 ' HA ' ' HE1' ' A' ' 94' ' ' HIS . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt -80.69 3.94 20.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.795 ' HB3' HH21 ' A' ' 109' ' ' ARG . 64.6 m80 -119.61 165.42 14.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.252 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -150.7 168.51 10.88 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.19 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 35.1 Cg_endo -65.51 53.55 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.905 2.404 . . . . 0.0 112.372 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -155.44 20.95 0.55 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -113.93 175.07 5.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 26.1 t70 -93.23 123.97 59.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 24.6 Cg_exo -64.53 83.14 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.956 2.438 . . . . 0.0 112.157 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.1 mtm -79.88 -40.92 27.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.023 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -156.2 1.75 0.15 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.361 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.35 -167.42 1.19 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.335 0.254 . . . . 0.0 110.878 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.2 60.26 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.09 0.948 . . . . 0.0 109.497 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 t -154.64 49.48 0.6 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.553 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m 67.94 77.29 0.25 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.838 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.92 121.29 3.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.132 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.84 150.08 39.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.795 HH21 ' HB3' ' A' ' 94' ' ' HIS . 32.2 mmm-85 -117.45 178.17 4.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo -42.29 117.22 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 0.6 OUTLIER -78.53 -8.83 58.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -164.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 131' ' ' ASN . 20.2 t70 79.4 -15.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.59 0.556 . . . . 0.0 111.293 173.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -76.64 74.39 3.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.491 ' HB3' ' ND2' ' A' ' 81' ' ' ASN . 25.4 p -176.21 174.03 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.71 57.63 0.28 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 166.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.619 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 4.5 pt20 -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.476 0.179 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.88 -173.44 1.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 44' ' ' PRO . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.554 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.737 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 1' ' ' MET . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.68 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.646 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.594 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.445 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.621 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.469 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.573 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.621 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 16.6 mt -82.81 27.92 0.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 110' ' ' TRP . 46.4 t-80 102.62 87.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.873 1.358 . . . . 0.0 111.001 165.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -150.9 56.41 2.05 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.057 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 95' ' ' ALA . 6.3 Cg_exo -79.54 -60.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.507 2.138 . . . . 0.0 111.25 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.99 35.82 2.65 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.41 121.17 32.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.484 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 11.4 t70 69.98 138.8 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.112 0.883 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 17.1 Cg_exo -67.27 79.53 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.054 2.502 . . . . 0.0 112.94 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 103' ' ' TYR . 65.3 mtm -148.42 -178.09 6.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.56 56.78 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.563 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HE2' ' SD ' ' A' ' 101' ' ' MET . 65.9 m-85 -71.22 153.4 42.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.419 . . . . 0.0 111.383 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.01 115.08 0.97 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.743 171.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 t -156.27 67.91 0.6 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t 68.77 27.71 5.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.899 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.73 103.92 7.96 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.41 166.82 22.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.216 0.531 . . . . 0.0 111.039 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -118.51 153.51 34.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.817 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.646 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.689 ' HB3' HD11 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 93' ' ' LEU . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo -52.92 107.15 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.7 169.71 17.11 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.494 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 55.96 61.15 2.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.236 0.96 . . . . 0.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -74.34 68.16 1.49 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.484 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.419 ' O ' ' HE3' ' A' ' 101' ' ' MET . 78.9 p -63.51 -7.33 6.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' ' CE ' ' A' ' 101' ' ' MET . . . 99.22 48.73 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.364 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.413 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 77' ' ' MET . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.61 0.243 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.657 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 9.0 t30 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.714 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.549 HG21 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.501 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.51 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.9 t-20 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 88' ' ' VAL . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.511 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 93' ' ' LEU . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.656 HG12 ' NE2' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.44 ' H ' HG13 ' A' ' 90' ' ' ILE . 15.5 mt . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.709 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.932 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.656 ' NE2' HG12 ' A' ' 92' ' ' ILE . 47.6 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo . . . . . 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.494 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.51 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.1 OUTLIER -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.552 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.571 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.458 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.645 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.442 HD21 HG23 ' A' ' 90' ' ' ILE . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 119' ' ' ILE . 89.9 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.756 0.312 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.813 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 27.0 mm-40 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 93' ' ' LEU . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.416 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 126' ' ' MET . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.821 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 148' ' ' ARG . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.821 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 2.9 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' HD21 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HZ3' HD12 ' A' ' 16' ' ' LEU . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.705 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.688 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.668 HG21 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.705 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' HE2' ' HE2' ' A' ' 143' ' ' MET . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? . . . . . 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.476 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.757 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 12' ' ' GLU . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.757 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.456 HD11 ' HZ3' ' A' ' 110' ' ' TRP . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.229 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.63 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.525 ' HE2' ' HE2' ' A' ' 78' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 48' ' ' CYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.627 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 161' ' ' LYS . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.53 HG13 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 17.6 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.627 ' HE2' ' HG2' ' A' ' 157' ' ' GLN . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 51' ' ' PHE . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.658 0.266 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.654 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 HG23 HD23 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 8.6 t30 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.782 ' HB2' HG21 ' A' ' 47' ' ' THR . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.603 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HD12 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.508 HD21 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' HA ' HD21 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 119' ' ' ILE . 18.0 mt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.3 mpt_? . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.654 0.264 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.409 ' HG2' HD23 ' A' ' 121' ' ' LEU . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 115' ' ' SER . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD23 ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.602 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 17.2 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 12.6 mm-40 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.535 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.8 t30 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' PHE . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.691 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 82' ' ' ILE . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.523 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.799 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.549 HG12 HG12 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.599 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.508 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 24' ' ' ILE . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.522 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.799 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.535 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 6.5 mm100 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.662 ' HB3' HD12 ' A' ' 165' ' ' LEU . 15.6 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB1' ' HZ ' ' A' ' 35' ' ' PHE . . . . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' OE2' HG22 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.488 HD22 ' HG3' ' A' ' 32' ' ' GLU . 2.5 p-10 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG3' HD22 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' HZ ' ' HB1' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.588 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HG3' HG13 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.47 ' CE1' HD21 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.643 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE2' ' HE1' ' A' ' 143' ' ' MET . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 83' ' ' TYR . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.544 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.677 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 92' ' ' ILE . 96.6 mt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.0 mmt-85 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.46 HG22 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.786 ' HA ' ' HE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo . . . . . 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.481 ' CB ' HD12 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.787 ' HE2' HG23 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.461 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.568 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.643 HG21 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.569 ' HB2' HG11 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.769 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.758 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 72' ' ' ARG . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.559 ' HA ' HG21 ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.528 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 93' ' ' LEU . 7.4 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.48 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 1.03 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 1.03 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.478 HG22 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.643 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 CA-C-O 120.103 -0.276 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.447 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.429 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.447 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 51' ' ' PHE . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.9 ' HB3' HD12 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.9 HD12 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 C--O 1.224 -0.26 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.601 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.471 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.506 HD22 ' HG2' ' A' ' 36' ' ' GLU . 6.7 t30 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.858 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.688 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.83 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG21 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.662 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.672 HG13 HG12 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.528 ' CZ3' HD11 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.47 ' HB3' ' OE2' ' A' ' 12' ' ' GLU . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 115' ' ' SER . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.528 HD11 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HB3' HG12 ' A' ' 24' ' ' ILE . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 80' ' ' PRO . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.626 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 144' ' ' TRP . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 154' ' ' ILE . 3.6 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.854 ' HB3' HE21 ' A' ' 15' ' ' GLN . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.854 HE21 ' HB3' ' A' ' 14' ' ' LYS . 12.8 mm-40 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.448 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.64 ' HB3' HD21 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB2' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ALA . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.772 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.667 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.662 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.47 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.658 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.2 mmm-85 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.751 0.31 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.619 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.3 OUTLIER -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 44' ' ' PRO . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.554 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.737 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.68 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.646 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.594 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.445 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.621 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.469 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.573 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.621 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 16.6 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.646 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.689 ' HB3' HD11 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 93' ' ' LEU . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.364 -0.294 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.413 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.442 HE21 ' CA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 77' ' ' MET . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 70.0 mtm . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.67 -168.8 1.84 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.48 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.59 -73.61 2.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.723 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 3.4 t -68.12 -24.93 65.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.3 0.572 . . . . 0.0 110.111 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.49 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.689 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.63 -50.11 73.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.732 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 17.8 ptpt -60.64 -36.26 78.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 10.5 tpt180 -62.73 -43.85 97.73 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.027 0.442 . . . . 0.0 109.883 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.45 -22.11 60.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.241 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.7 mmt -72.92 -39.04 66.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.8 94.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.103 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.6 mm-40 -56.94 -46.85 81.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.174 0.511 . . . . 0.0 109.847 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -52.74 -65.99 0.46 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -46.86 -52.45 14.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.441 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -33.7 72.58 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.066 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.39 -35.96 82.6 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.8 m -72.5 -47.61 47.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.45 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -47.06 62.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.697 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -124.64 78.85 63.21 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.83 115.33 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.69 2.26 . . . . 0.0 112.211 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -66.21 150.63 84.78 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.219 1.946 . . . . 0.0 111.775 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.41 146.72 44.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.627 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 79.04 -13.13 21.11 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.892 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.9 mp -121.56 125.91 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 119.04 1.42 . . . . 0.0 110.594 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 37.5 t -127.99 114.03 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.17 142.95 26.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 119.299 0.954 . . . . 0.0 111.976 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.26 158.82 28.44 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 57.7 Cg_endo -70.6 148.97 60.76 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.73 2.287 . . . . 0.0 112.883 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.657 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . 97.5 mmm -84.09 92.14 7.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.922 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 42.9 t30 74.39 119.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 O-C-N 124.289 0.993 . . . . 0.0 110.028 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -2.95 2.78 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.531 -172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.98 -49.02 10.02 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.298 0.57 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 9.0 t30 -101.08 88.95 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.03 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -78.8 5.81 10.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.829 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.32 14.06 12.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 111.674 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 29' ' ' MET . 16.5 pt-20 -153.46 132.68 12.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 12.3 m0 -125.61 157.97 35.86 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -117.7 142.56 47.11 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -137.36 150.11 47.47 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.19 0.519 . . . . 0.0 110.928 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 5.9 mp -113.55 117.12 30.75 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 47.0 mm -96.84 100.21 10.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.714 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 21.1 mmt -75.91 114.15 14.21 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.765 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -55.86 135.81 48.53 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.238 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HG3' HG13 ' A' ' 124' ' ' VAL . 74.6 Cg_exo -50.82 131.36 33.81 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 123.086 2.524 . . . . 0.0 112.069 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -66.68 151.84 46.58 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.8 t70 72.32 20.95 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 124.174 0.921 . . . . 0.0 110.454 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.549 HG21 ' CB ' ' A' ' 128' ' ' ALA . 10.4 p -131.74 175.72 8.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.802 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.5 m -80.6 5.64 14.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.634 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 80.4 m-85 -119.21 -1.01 10.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 7.8 pt-20 -36.44 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.501 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 96.8 m-85 -37.72 -18.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 174.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.17 140.92 34.86 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.459 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 62.1 t -123.23 96.3 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 174.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 25.1 m-85 -98.71 106.42 36.91 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -168.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 51.6 Cg_endo -77.15 140.58 19.99 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.19 1.927 . . . . 0.0 112.124 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -145.98 164.05 33.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.6 132.85 70.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.825 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 7.9 mp -109.1 121.17 44.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.643 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 34.7 t -103.63 119.02 38.07 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.487 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -99.13 131.66 24.89 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 110.619 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 63' ' ' ASP . 42.8 Cg_endo -83.14 161.31 15.47 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.105 2.537 . . . . 0.0 112.32 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 1' ' ' MET . 95.6 mt -76.06 31.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.311 172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 61' ' ' PRO . 22.0 m-20 -130.9 -2.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.878 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -63.74 145.38 97.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 28.8 Cg_endo -95.64 18.16 35.13 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.809 -0.913 . . . . 0.0 112.56 0.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mt -67.68 -41.79 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.15 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.3 m -114.36 148.83 41.02 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.453 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 138.98 53.04 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.137 2.558 . . . . 0.0 112.677 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 Cg_endo -76.5 172.67 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.87 2.38 . . . . 0.0 111.966 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 37.7 mtmt -104.1 150.14 24.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.17 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.6 ttt -152.44 134.45 14.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -143.11 144.95 32.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.836 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 82.2 m-85 -90.37 133.9 34.69 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 175.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.0 p -86.17 -38.26 17.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 40.8 t -92.31 46.59 1.26 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' CYS . 5.9 pt-20 37.84 -163.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.817 1.247 . . . . 0.0 114.19 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 46.2 ttm -178.87 178.18 0.79 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.861 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' HG2' ' A' ' 77' ' ' MET . 21.0 t80 -146.66 99.3 3.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.431 0.634 . . . . 0.0 110.12 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.51 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 54.1 t-80 -159.41 135.88 6.49 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.334 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 12.4 Cg_endo -56.15 -35.0 94.58 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.859 3.04 . . . . 0.0 114.333 -174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 131' ' ' ASN . 1.9 t-20 -86.84 25.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.554 0.692 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 88' ' ' VAL . 6.9 mt -139.94 141.03 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.143 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.537 ' CD1' ' HB1' ' A' ' 136' ' ' ALA . 30.3 m-85 -64.82 149.71 95.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.426 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.66 -20.76 40.12 Favored 'Trans proline' 0 CA--C 1.512 -0.596 0 C-N-CA 122.85 2.367 . . . . 0.0 110.381 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -77.65 3.81 12.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.241 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.13 6.08 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.62 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -53.97 141.33 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.31 0.576 . . . . 0.0 112.288 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.511 ' HA ' HG23 ' A' ' 82' ' ' ILE . 51.1 t -84.96 116.32 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.084 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 52.9 t -115.46 70.34 0.74 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.041 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 93' ' ' LEU . 42.1 pt -103.86 154.56 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.827 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.604 ' HB3' ' HG3' ' A' ' 133' ' ' GLU . 2.6 p -64.43 -31.21 72.33 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.656 HG12 ' NE2' ' A' ' 114' ' ' GLN . 6.5 tt -89.02 -24.03 6.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.308 -175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.44 ' H ' HG13 ' A' ' 90' ' ' ILE . 15.5 mt -87.91 12.35 13.41 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.072 0.463 . . . . 0.0 110.5 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 1.6 m80 -103.54 153.03 21.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.501 0.667 . . . . 0.0 110.946 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.4 143.24 36.2 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.568 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 110' ' ' TRP . 31.6 Cg_exo -62.05 105.45 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.584 2.189 . . . . 0.0 110.983 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.47 -26.0 7.12 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -89.47 64.3 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.22 91.32 19.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -89.36 -163.09 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.092 2.528 . . . . 0.0 113.652 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.4 mtp 68.34 -69.42 0.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.983 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -165.74 -36.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.479 -1.343 . . . . 0.0 114.545 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -68.83 168.7 12.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.343 0.592 . . . . 0.0 112.121 -171.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.17 159.98 15.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.315 -169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 m -79.24 14.9 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.9 m -76.5 -15.99 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.083 0.468 . . . . 0.0 110.078 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.54 171.29 14.54 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.65 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -71.65 136.99 47.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.089 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 94' ' ' HIS . 1.0 OUTLIER -144.08 -178.22 5.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.798 -175.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.709 ' CZ2' ' HA ' ' A' ' 113' ' ' VAL . 28.3 t-105 -42.16 117.78 1.04 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.241 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.932 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 66.0 m -92.25 -166.0 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.416 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.932 ' HD2' ' HB3' ' A' ' 111' ' ' SER . 18.2 Cg_endo -62.59 63.18 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.874 1.716 . . . . 0.0 111.11 163.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 112' ' ' PRO . 1.6 p 71.2 -17.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.56 1.944 . . . . 0.0 113.301 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.656 ' NE2' HG12 ' A' ' 92' ' ' ILE . 47.6 mt-30 59.86 -141.46 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -145.94 151.03 37.17 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.0 m -51.18 -33.65 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.451 0.569 . . . . 0.0 111.363 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 121' ' ' LEU . 3.9 tm-20 -68.01 -39.31 83.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.375 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -67.1 -44.92 78.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.54 -51.84 66.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.703 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.486 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.3 mp -73.5 -25.24 60.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 117' ' ' GLU . 2.5 mm? -69.62 -32.43 71.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.222 0.534 . . . . 0.0 109.794 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.0 t -65.75 -37.11 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.2 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.61 -43.27 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.543 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.529 HG13 ' HG3' ' A' ' 44' ' ' PRO . 92.0 t -62.59 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.057 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.9 t -58.28 -39.6 79.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.332 0.587 . . . . 0.0 109.756 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 51.9 ttp -63.68 -33.5 75.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.919 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 mt -85.68 -28.96 24.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -90.94 -28.91 17.75 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.73 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -121.15 88.71 45.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.825 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.494 ' HG2' ' CH2' ' A' ' 144' ' ' TRP . 51.7 Cg_exo -52.64 112.43 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.779 2.32 . . . . 0.0 112.764 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 44.4 t30 -108.33 123.48 48.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.955 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -95.27 54.22 1.61 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.565 0.698 . . . . 0.0 110.57 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' HG3' ' HB3' ' A' ' 91' ' ' SER . 0.3 OUTLIER -68.89 120.13 14.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.298 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t 72.33 -55.84 0.66 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.979 0.799 . . . . 0.0 110.382 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.48 1.43 Allowed Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 83' ' ' TYR . . . -58.65 -43.99 89.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.328 0.585 . . . . 0.0 109.931 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 35.6 t-20 -100.93 94.63 6.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.855 173.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 48.9 t -63.59 -33.74 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.787 -175.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.28 -37.24 83.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.272 0.558 . . . . 0.0 109.996 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 137' ' ' ASN . . . -73.04 -37.53 66.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.152 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 15.5 p -73.69 -35.07 65.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' VAL . 6.8 tmtt? -58.71 -58.82 6.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.355 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.7 mtm -69.14 -14.2 62.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.494 ' CH2' ' HG2' ' A' ' 130' ' ' PRO . 36.7 t-105 -81.16 -38.95 26.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.581 . . . . 0.0 109.948 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -79.5 -36.38 38.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.767 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -79.0 -67.55 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.573 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -126.89 95.55 4.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.25 0.548 . . . . 0.0 110.973 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -52.79 -35.38 56.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.699 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.23 -41.29 79.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.195 0.522 . . . . 0.0 110.644 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.51 ' O ' HG13 ' A' ' 154' ' ' ILE . 7.6 tp-100 -66.56 -44.06 83.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -61.65 -47.97 82.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.463 . . . . 0.0 110.171 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 20.4 m-30 -52.44 -47.6 66.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.118 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -70.33 -37.07 74.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.498 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 80.8 mt -61.84 -40.29 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.191 0.519 . . . . 0.0 109.729 174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.88 -44.5 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.83 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 28.0 mmmt -66.28 -33.88 76.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.874 0.369 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.1 OUTLIER -72.22 -36.85 69.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.239 -177.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.2 mm -64.38 -36.71 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 20.5 t -56.83 -52.66 52.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.12 177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 157' ' ' GLN . 4.6 pt20 -69.68 -34.43 73.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.235 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.82 -34.64 77.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.026 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.0 m -64.79 -29.73 70.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.546 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.11 -31.17 49.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.346 0.593 . . . . 0.0 110.029 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.65 43.81 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.218 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.324 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 120.91 0.386 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.57 -22.91 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.112 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -43.23 87.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.263 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.8 m -69.43 -26.69 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.642 0.721 . . . . 0.0 110.02 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.57 69.49 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.09 -49.09 72.55 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.618 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -56.85 -48.63 77.64 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.645 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.5 tpt180 -65.57 -41.49 92.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 110.38 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.45 -27.19 65.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.614 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.8 mmt -67.46 -40.9 85.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.08 92.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.458 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -59.38 -51.31 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 111.167 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -52.4 -62.4 1.67 Allowed 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 17' ' ' THR . 49.8 mtpt -56.65 -35.3 68.23 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.176 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.552 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -67.32 -30.46 70.31 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.297 -0.877 . . . . 0.0 111.067 175.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 25.9 mt -74.45 -0.6 17.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.352 0.596 . . . . 0.0 110.518 172.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 14' ' ' LYS . 24.1 m -98.15 -46.13 5.96 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.0 -45.38 64.09 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.038 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -104.73 117.97 57.55 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.754 0.311 . . . . 0.0 110.5 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 57.9 Cg_endo -98.93 98.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.529 2.819 . . . . 0.0 112.0 172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 2.1 Cg_endo -49.47 -97.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.354 2.703 . . . . 0.0 112.458 172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 12.4 pt-20 -174.32 119.17 0.24 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.066 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.62 30.25 66.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.982 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 120' ' ' LEU . 25.7 mm -119.92 119.34 59.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -125.75 113.61 35.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.06 141.01 23.75 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.336 -0.852 . . . . 0.0 111.692 -172.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -155.66 151.59 23.12 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.373 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.5 Cg_exo -64.76 147.12 89.56 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.683 2.255 . . . . 0.0 111.373 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 92.6 mmm -81.22 91.68 6.22 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.571 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 49.6 t30 75.53 122.25 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 O-C-N 124.651 1.219 . . . . 0.0 109.939 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.94 0.25 2.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.133 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.571 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 38.3 mt-10 -85.24 -22.47 28.63 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.308 0.575 . . . . 0.0 110.835 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -127.81 89.68 2.98 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.74 7.5 20.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.157 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -93.29 8.48 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.458 ' C ' ' HD1' ' A' ' 37' ' ' TRP . 10.7 pt-20 -151.77 131.15 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.207 0.527 . . . . 0.0 110.259 171.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 25.8 m0 -125.29 156.29 38.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -112.35 138.71 48.68 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.22 142.33 48.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.209 0.528 . . . . 0.0 110.356 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 25' ' ' VAL . 2.5 mm? -108.26 120.57 42.73 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -104.56 99.78 9.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.1 mmt -77.5 121.37 23.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.157 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -49.21 126.79 19.91 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.699 0.624 . . . . 0.0 114.093 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.711 ' HB2' HG21 ' A' ' 47' ' ' THR . 91.9 Cg_exo -48.92 133.71 28.27 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.033 3.155 . . . . 0.0 112.26 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -65.44 145.0 56.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 t70 74.36 26.25 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 110.407 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.711 HG21 ' HB2' ' A' ' 44' ' ' PRO . 16.1 p -126.37 171.92 10.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.455 0.645 . . . . 0.0 110.703 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.98 16.52 3.36 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.286 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 57.0 m-85 -129.85 5.51 5.02 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.465 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' PRO . 12.2 pt-20 -69.36 160.24 31.67 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.605 0.241 . . . . 0.0 111.401 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 22.1 m-85 75.8 -14.51 0.78 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.772 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.31 153.65 33.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.187 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.7 t -124.3 97.87 4.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -100.39 109.32 56.6 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 120.846 0.355 . . . . 0.0 110.382 -170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 139.92 15.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.735 2.29 . . . . 0.0 112.267 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.18 160.85 40.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' MET . 73.2 mt -121.01 134.63 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.779 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 7.2 mp -116.62 120.74 39.61 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 87.4 p -106.37 126.68 52.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 99.4 m-85 -104.13 138.67 19.59 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.508 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 37.5 Cg_endo -82.96 158.72 15.7 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.114 2.543 . . . . 0.0 112.263 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.43 37.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.97 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 47.7 m-20 -134.25 -9.02 2.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.367 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 8' ' ' ARG . 20.2 t80 -55.8 134.27 72.66 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.687 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.645 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 63.4 Cg_endo -94.72 92.74 0.14 OUTLIER 'Cis proline' 0 CA--C 1.545 1.069 0 CA-C-N 119.523 0.865 . . . . 0.0 112.843 -0.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 36.4 mt -144.02 -40.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.873 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.496 ' HB3' ' HG3' ' A' ' 61' ' ' PRO . 8.1 t -117.1 136.06 23.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.08 131.7 33.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.857 2.372 . . . . 0.0 112.037 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 28.1 Cg_endo -64.57 153.01 79.57 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.379 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 59' ' ' SER . 19.2 ttmm -94.55 151.85 19.01 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 27.8 ttt -149.58 131.83 15.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.915 0.388 . . . . 0.0 110.63 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 ptt85 -145.06 148.79 34.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.876 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.45 138.76 31.29 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -86.5 -40.68 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.49 171.15 12.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -72.69 155.77 39.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.031 0.443 . . . . 0.0 110.887 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 158' ' ' ILE . 25.7 ttt -164.17 175.4 10.2 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' H ' ' HG2' ' A' ' 77' ' ' MET . 32.9 t80 -151.35 100.85 2.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.311 0.577 . . . . 0.0 110.092 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 34.4 t-80 -151.48 135.17 9.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.177 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.4 Cg_endo -59.11 -32.32 97.1 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.401 2.734 . . . . 0.0 113.443 -174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.442 HD21 HG23 ' A' ' 90' ' ' ILE . 21.6 t30 -80.8 17.02 1.24 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.315 0.579 . . . . 0.0 111.601 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 10.7 mt -128.8 133.17 66.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.269 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 89' ' ' CYS . 10.6 m-85 -72.59 163.95 63.83 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.557 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -63.18 -25.58 72.62 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 111.276 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.39 -3.47 30.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.92 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.76 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.342 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -58.77 136.32 57.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 111.021 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.8 130.49 35.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.808 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 42.5 t -112.7 110.18 20.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.739 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -143.57 135.42 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 173.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.8 m -50.66 -29.5 11.25 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.876 0.735 . . . . 0.0 112.768 -170.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 114' ' ' GLN . 5.7 tt -65.1 -47.56 87.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.185 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 119' ' ' ILE . 89.9 mt -89.43 -3.96 58.19 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -84.77 -64.22 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 109' ' ' ARG . . . -154.79 138.14 10.69 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 110' ' ' TRP . 79.0 Cg_endo -78.52 2.78 7.8 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.551 2.168 . . . . 0.0 114.199 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.52 42.4 0.11 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.136 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.2 -160.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.749 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.901 ' HB2' HH22 ' A' ' 109' ' ' ARG . 47.0 m-20 63.77 86.33 0.15 Allowed Pre-proline 0 C--O 1.234 0.276 0 O-C-N 124.038 0.836 . . . . 0.0 112.632 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.2 70.92 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.248 1.965 . . . . 0.0 110.608 170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.481 ' HG3' ' HB3' ' A' ' 99' ' ' ASP . 55.2 mtt -84.87 -24.14 28.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.15 -174.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.79 77.58 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.243 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -71.03 150.99 45.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.655 0.74 . . . . 0.0 111.454 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 105' ' ' SER . 22.1 pt-20 -123.24 -166.61 1.48 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.482 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 33.4 t 73.99 -67.58 0.25 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.694 0.621 . . . . 0.0 110.857 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -150.98 123.13 8.26 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.65 45.94 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.18 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 5.6 pt-20 -73.1 168.55 18.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.878 0.371 . . . . 0.0 110.647 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.901 HH22 ' HB2' ' A' ' 99' ' ' ASP . 16.1 mmt180 -128.89 161.83 28.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.705 -164.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 76.5 t-105 -59.49 106.59 0.47 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.122 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.2 m -107.39 161.41 23.16 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -57.79 -5.17 1.72 Allowed 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.438 2.759 . . . . 0.0 114.29 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 113' ' ' VAL . 14.7 p -139.49 65.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 122.602 1.192 . . . . 0.0 111.552 175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.813 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 27.0 mm-40 -87.8 -17.27 31.94 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.741 173.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 119' ' ' ILE . 20.9 t 50.34 128.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.123 1.369 . . . . 0.0 114.01 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.1 m -60.18 -26.77 37.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.919 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 4.4 tt0 -68.03 -44.52 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.813 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 61.7 mttm -65.37 -34.68 78.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.212 0.53 . . . . 0.0 110.375 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 HD21 ' A' ' 93' ' ' LEU . 90.2 mt -66.69 -53.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.922 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 24' ' ' ILE . 10.4 mp -68.93 -24.73 64.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.257 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -67.29 -36.57 81.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.416 ' HA ' ' OG ' ' A' ' 125' ' ' SER . 70.0 m -69.84 -25.84 63.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.36 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 126' ' ' MET . 90.0 t -68.76 -43.21 83.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.35 0.595 . . . . 0.0 109.641 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 44' ' ' PRO . 98.5 t -64.33 -43.42 97.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.761 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.416 ' OG ' ' HA ' ' A' ' 122' ' ' SER . 44.7 p -68.14 -37.29 80.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.197 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.0 ptt? -66.58 -30.41 70.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.588 0.232 . . . . 0.0 111.019 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 93.3 mt -73.56 -28.71 62.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.594 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 47' ' ' THR . . . -94.39 -32.41 13.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.0 0.429 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.92 93.04 35.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.555 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.28 -0.71 5.29 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.296 2.664 . . . . 0.0 113.692 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.57 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 7.7 t30 -30.96 -64.43 0.14 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.127 0.571 . . . . 0.0 112.494 172.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.85 75.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.338 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 131' ' ' ASN . 46.7 mt-10 -80.45 -34.47 35.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.02 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.9 t 72.9 -28.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.949 0.899 . . . . 0.0 112.221 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.08 42.99 4.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.647 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 89' ' ' CYS . . . -96.2 -71.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.673 0.273 . . . . 0.0 111.337 -174.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 41.6 t-20 -96.93 109.86 22.5 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.82 -41.04 91.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.305 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.45 -40.89 96.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.981 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.51 66.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.765 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 19.3 p -78.45 -47.42 17.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.605 0.241 . . . . 0.0 111.163 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -58.84 -49.12 78.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.665 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.43 ' SD ' ' NE2' ' A' ' 150' ' ' GLN . 50.6 ttp -61.21 -42.49 98.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.022 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.7 t-105 -52.28 -37.42 55.54 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.563 0.22 . . . . 0.0 111.413 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 141' ' ' SER . 25.0 mmm180 -70.25 -35.73 74.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.064 0.459 . . . . 0.0 110.315 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -95.11 -78.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.039 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -101.35 87.55 3.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.364 0.602 . . . . 0.0 111.204 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 51.0 mtt180 -54.45 -35.51 63.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.543 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -59.21 -39.54 82.98 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -172.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.821 ' HG2' ' HE2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -77.23 -31.19 54.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.419 -178.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -61.85 -52.7 63.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.624 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 148' ' ' ARG . 19.4 m-85 -55.63 -44.39 77.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.418 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.821 ' HE2' ' HG2' ' A' ' 150' ' ' GLN . 44.9 pttt -67.03 -42.6 84.58 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.93 -177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 158' ' ' ILE . 81.3 mt -64.44 -38.66 83.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.754 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.19 -48.63 77.56 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.04 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 97.8 mttt -68.04 -28.65 67.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.187 0.518 . . . . 0.0 110.534 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 161' ' ' LYS . 2.9 tt0 -65.23 -44.44 88.21 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.916 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.7 mm -61.13 -34.52 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.234 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 162' ' ' SER . 42.9 t -56.87 -52.45 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.061 0.458 . . . . 0.0 110.865 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.556 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.9 pt20 -74.72 -28.24 60.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.455 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 10.1 mptt -63.05 -36.06 82.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.488 0.661 . . . . 0.0 110.244 172.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 159' ' ' VAL . 16.7 t -60.98 -38.66 86.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.214 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 70.5 mt -76.16 -33.17 59.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 118.13 35.18 1.05 Allowed Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.781 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 160' ' ' GLN . 77.3 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.901 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.899 0.38 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.24 -165.76 2.15 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.08 -72.98 2.39 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.537 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 t -68.9 -29.5 67.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.257 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.68 -47.88 76.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 10' ' ' MET . 85.2 mt -59.7 -45.45 92.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.981 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -55.39 -40.97 72.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.522 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.656 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 9.3 tpp180 -64.22 -49.49 71.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.185 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 34' ' ' PHE . 66.6 mt -68.17 -26.66 65.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.842 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 24.6 mmt -68.29 -41.23 81.27 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -64.46 -44.59 90.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.17 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 10.7 mm-40 -57.84 -48.24 80.33 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.218 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.4 -60.78 2.53 Favored 'General case' 0 CA--C 1.509 -0.635 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.282 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 10' ' ' MET . 27.0 mtpp -53.11 -43.83 67.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.13 -1.395 . . . . 0.0 113.436 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 14.1 mm-40 -63.3 -35.9 81.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.075 0.852 . . . . 0.0 110.059 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 76.6 mt -67.41 -23.3 65.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.552 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -78.82 -46.77 17.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.979 0.419 . . . . 0.0 110.011 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.12 -47.62 76.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.149 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -141.89 89.99 8.71 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.48 0.181 . . . . 0.0 110.527 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 3.6 Cg_exo -75.48 114.26 3.94 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.648 2.232 . . . . 0.0 111.722 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' HD21 ' A' ' 121' ' ' LEU . 4.1 Cg_exo -42.77 138.93 3.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.827 3.018 . . . . 0.0 112.59 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.41 130.79 44.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.901 0.858 . . . . 0.0 111.863 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.31 17.26 77.44 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.371 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 21' ' ' PRO . 34.0 mm -121.7 121.51 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.095 0.474 . . . . 0.0 109.777 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 55.7 t -123.34 106.19 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.47 141.0 27.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.824 -0.751 . . . . 0.0 111.772 -170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.28 171.22 41.25 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.49 132.73 47.67 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.804 2.336 . . . . 0.0 111.623 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 ttt -52.77 -21.42 4.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.309 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -163.0 136.1 5.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -71.33 53.34 0.19 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -155.62 -40.69 0.08 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.489 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -92.18 102.01 14.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.267 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' LEU . 6.7 m-85 -94.36 -0.45 54.89 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -92.63 4.34 53.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 110.26 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -142.17 122.18 13.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.558 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' HZ3' HD12 ' A' ' 16' ' ' LEU . 14.4 m0 -124.97 158.09 34.49 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.705 ' HG2' HG12 ' A' ' 57' ' ' ILE . 30.5 mt-10 -122.12 148.99 44.21 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.27 148.67 38.43 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.255 0.55 . . . . 0.0 111.091 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 7.1 mp -109.58 120.56 42.87 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.45 100.63 10.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 20.5 mmt -75.07 114.78 13.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.48 126.12 27.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.811 -1.086 . . . . 0.0 114.129 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.688 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 80.6 Cg_exo -45.0 123.76 5.32 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.8 3.0 . . . . 0.0 112.445 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.15 151.44 45.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.109 0.48 . . . . 0.0 111.208 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.63 21.66 4.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.4 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.668 HG21 ' HA ' ' A' ' 128' ' ' ALA . 5.2 p -127.83 177.52 6.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 2.1 p -70.49 -22.36 62.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.71 175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -94.42 5.81 50.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 43.7 tt0 -57.16 141.87 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.107 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 35.2 m-85 83.6 -19.29 0.39 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.194 0.934 . . . . 0.0 111.832 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -70.3 155.43 53.06 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.632 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.7 t -131.86 98.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -104.66 109.64 63.23 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.683 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.77 146.39 18.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.292 1.995 . . . . 0.0 112.212 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.284 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.705 HG12 ' HG2' ' A' ' 38' ' ' GLU . 64.0 mt -122.2 132.99 69.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.745 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.1 mp -106.63 117.03 32.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.132 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.0 t -103.23 120.72 41.26 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -101.44 138.26 19.85 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.217 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 63' ' ' ASP . 46.9 Cg_endo -81.75 160.51 18.95 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.082 2.521 . . . . 0.0 111.809 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.7 35.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.205 0.526 . . . . 0.0 110.449 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 61' ' ' PRO . 11.2 m-20 -143.83 5.79 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.17 142.74 97.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.656 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 29.9 Cg_endo -97.73 29.63 14.5 Favored 'Cis proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.668 -0.971 . . . . 0.0 112.64 0.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 96.1 mt -79.03 -41.55 28.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.456 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 67.4 m -101.26 142.97 25.67 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.264 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 39.7 Cg_exo -60.7 132.61 43.68 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.108 2.538 . . . . 0.0 112.836 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.02 158.7 55.77 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.888 2.392 . . . . 0.0 111.905 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 15.8 ttmm -103.39 148.62 25.67 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.6 ttt -154.45 125.8 7.4 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.686 0.279 . . . . 0.0 110.423 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 33.2 ptt85 -146.61 149.77 34.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.382 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 88.2 m-85 -85.03 139.73 31.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.783 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.1 p -86.98 -39.5 15.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.216 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 76' ' ' GLU . 44.8 t -83.29 173.31 11.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 7.1 tp10 -62.74 144.87 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.037 0.446 . . . . 0.0 110.924 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.2 tpp -145.52 156.48 43.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.588 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' HE2' ' HE2' ' A' ' 143' ' ' MET . 30.4 t80 -150.62 99.96 2.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.475 0.655 . . . . 0.0 110.246 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 55.1 t-80 -151.12 141.6 14.7 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.346 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HB3' ' CA ' ' A' ' 141' ' ' SER . 47.3 Cg_endo -69.28 39.8 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.748 2.966 . . . . 0.0 113.892 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 134' ' ' SER . 12.8 t-20 -159.41 19.98 0.18 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.669 0.747 . . . . 0.0 109.051 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.39 126.09 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.291 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 50.7 m-85 -68.44 168.69 13.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.889 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 38.9 Cg_endo -66.39 -28.47 46.5 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.016 1.81 . . . . 0.0 111.177 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 8.2 p-10 -81.26 8.74 8.29 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.256 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.67 85.93 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.185 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 13.8 ttm180 -53.31 132.01 38.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.65 134.96 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.044 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 90' ' ' ILE . 45.0 t -124.82 147.26 48.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -159.47 158.88 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 172.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 50.7 m -47.48 -52.79 16.11 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.369 0.418 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 114' ' ' GLN . 7.9 tt -60.09 -28.92 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 34.7 mt -87.07 15.03 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.045 -0.41 . . . . 0.0 111.333 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' HB3' ' HA ' ' A' ' 104' ' ' GLU . 13.5 m170 99.78 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.757 1.223 . . . . 0.0 110.467 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 96' ' ' PRO . . . -165.74 56.62 0.43 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.521 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.661 ' HB3' ' HD2' ' A' ' 109' ' ' ARG . 83.2 Cg_endo -93.31 -153.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.338 2.025 . . . . 0.0 111.275 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.53 47.6 1.45 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.24 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.623 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . 24.6 t70 -99.79 34.81 2.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.179 0.514 . . . . 0.0 109.693 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.1 t70 64.74 98.96 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.635 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' MET . 83.1 Cg_exo -44.81 141.71 5.68 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.553 2.836 . . . . 0.0 113.219 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 22.9 mmt 73.14 -45.68 0.63 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.592 0.757 . . . . 0.0 111.911 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.62 -1.39 76.92 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 170.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.457 ' C ' ' HD1' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -70.32 -170.48 0.38 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.693 -0.753 . . . . 0.0 110.769 178.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' A' ' 94' ' ' HIS . 0.8 OUTLIER 67.12 179.18 0.22 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.418 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 38.6 t 68.25 -76.54 0.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.753 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 p -106.86 12.56 28.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.679 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.81 118.63 19.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.882 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 112.15 9.58 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' NE ' ' A' ' 109' ' ' ARG . 3.8 mmp_? -160.24 -65.9 0.07 Allowed 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -171.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 28.4 t-105 -68.21 140.33 56.07 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.923 170.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.476 ' HB3' ' CD ' ' A' ' 112' ' ' PRO . 43.3 m -154.2 -178.91 0.95 Allowed Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 111' ' ' SER . 31.5 Cg_exo -62.15 -18.09 60.11 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.719 1.613 . . . . 0.0 114.206 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.24 16.62 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 121.641 0.734 . . . . 0.0 111.951 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.757 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 6.0 mp0 -88.21 -26.25 22.48 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.385 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 12' ' ' GLU . 67.0 p 44.52 134.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.97 -31.41 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.875 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 21' ' ' PRO . 53.6 tt0 -69.44 -52.45 26.64 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.166 -0.213 . . . . 0.0 110.695 176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.757 ' HB2' ' O ' ' A' ' 114' ' ' GLN . 53.1 mtpt -58.27 -37.48 75.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.595 0.236 . . . . 0.0 110.963 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.456 HD11 ' HZ3' ' A' ' 110' ' ' TRP . 72.1 mt -60.03 -53.48 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.802 175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.1 mp -66.07 -31.6 72.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.857 -175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.9 mm? -64.64 -37.32 87.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.083 0.468 . . . . 0.0 110.23 174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.6 t -67.49 -36.1 80.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.511 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 119' ' ' ILE . 85.4 t -63.16 -49.68 82.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.71 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 24' ' ' ILE . 83.7 t -56.66 -45.41 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 111.049 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m -66.5 -34.96 79.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.5 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -67.4 -35.75 79.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.923 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.93 -35.36 57.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.627 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . . . -77.54 -28.77 52.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.303 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -135.58 94.93 14.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -53.58 108.89 0.31 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.715 2.277 . . . . 0.0 112.19 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.568 ' CG ' ' H ' ' A' ' 132' ' ' ASP . 10.9 t-20 -171.31 -162.99 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.856 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 131' ' ' ASN . 16.9 t70 82.75 -16.03 0.62 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -169.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 131' ' ' ASN . 15.6 tt0 56.96 -99.37 0.1 Allowed 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.397 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.479 ' HB2' ' OD1' ' A' ' 81' ' ' ASN . 66.5 m 49.17 86.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -75.64 50.96 2.59 Favored Glycine 0 C--O 1.228 -0.229 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.966 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.7 42.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.92 0.36 . . . . 0.0 111.699 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 33.9 t-20 -148.22 93.8 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.758 0.313 . . . . 0.0 110.609 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.55 -41.86 86.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.034 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -58.23 -43.71 87.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.184 0.516 . . . . 0.0 110.935 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.86 61.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.63 ' CA ' ' HB3' ' A' ' 80' ' ' PRO . 26.7 t -69.26 -49.47 55.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.283 0.563 . . . . 0.0 110.221 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -57.75 -53.65 55.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.748 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.525 ' HE2' ' HE2' ' A' ' 78' ' ' PHE . 52.3 ttp -61.17 -46.43 90.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.449 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -52.4 -45.64 65.94 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.983 0.421 . . . . 0.0 111.67 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -82.72 -29.22 29.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.309 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -82.38 -59.05 2.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.71 92.76 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.702 0.763 . . . . 0.0 110.181 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -58.33 -29.86 66.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.823 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.26 -40.7 94.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -60.39 -38.48 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.27 175.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -67.22 -47.58 70.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.147 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.413 ' HD1' ' HB3' ' A' ' 48' ' ' CYS . 17.7 m-85 -52.78 -50.68 63.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.793 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 8.1 ptmm? -65.31 -43.87 89.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.3 . . . . 0.0 111.479 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 157' ' ' GLN . 62.4 mt -68.46 -31.48 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.76 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -65.37 -44.52 87.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 110.306 176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 91.8 mttt -65.62 -33.37 75.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.544 0.688 . . . . 0.0 109.887 176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.627 ' HG2' ' HE2' ' A' ' 161' ' ' LYS . 5.3 tt0 -60.63 -46.42 90.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.036 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 161' ' ' LYS . 46.6 mm -63.29 -35.16 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.347 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.53 HG13 ' HA2' ' A' ' 52' ' ' GLY . 55.3 t -57.59 -50.41 77.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.506 176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 165' ' ' LEU . 17.6 mt-30 -60.6 -42.99 97.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.929 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.627 ' HE2' ' HG2' ' A' ' 157' ' ' GLN . 66.8 mttm -57.68 -46.74 83.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -76.56 -26.31 54.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.905 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 51' ' ' PHE . 15.8 mt -80.01 -30.48 39.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.82 82.94 1.6 Allowed Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.916 -167.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.1 pt? . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.128 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.16 63.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.172 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.83 -34.27 77.13 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.287 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 8.5 m -67.16 -33.17 74.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.052 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -68.49 -49.85 56.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.155 175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.2 tm? -55.39 -52.46 63.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.11 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -60.92 -36.32 78.99 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.654 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 6.9 tpt180 -69.13 -45.18 70.8 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.4 mt -65.96 -26.39 67.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.21 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 19.7 mmt -71.89 -39.31 69.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.34 -47.58 78.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.535 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 69.4 mm-40 -50.38 -47.75 56.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.184 0.516 . . . . 0.0 109.953 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 10' ' ' MET . 64.8 t80 -53.29 -64.62 0.76 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.667 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' MET . 30.8 mtpp -46.63 -54.95 8.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.633 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -68.69 -35.65 77.47 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 118.834 0.743 . . . . 0.0 111.553 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.67 -36.95 77.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.242 0.544 . . . . 0.0 110.506 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.3 m -70.87 -53.53 14.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.125 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 14' ' ' LYS . 4.0 mm? -74.65 -40.83 61.23 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.91 92.64 48.22 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 80.1 Cg_endo -80.27 128.89 7.4 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.426 2.084 . . . . 0.0 112.841 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 5.5 Cg_endo -54.07 -112.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.646 2.897 . . . . 0.0 113.006 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 21' ' ' PRO . 11.9 pt-20 -167.32 117.62 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.542 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.82 78.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.443 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 HG23 HD23 ' A' ' 120' ' ' LEU . 26.8 mm -120.1 123.21 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.83 124.47 67.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.5 137.04 15.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.278 0.944 . . . . 0.0 110.854 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -148.11 150.34 22.52 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.94 139.85 52.84 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.702 2.268 . . . . 0.0 111.964 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.495 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 16.2 tpt -77.95 94.59 4.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' MET . 31.7 t30 75.6 112.64 0.07 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.062 0.851 . . . . 0.0 109.845 -174.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -63.69 1.0 0.66 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -171.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -81.63 -56.21 4.16 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 36' ' ' GLU . 8.6 t30 -94.56 109.58 21.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.857 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.7 m-85 -93.5 4.07 54.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -90.96 17.72 7.54 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.919 -0.488 . . . . 0.0 112.149 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 29' ' ' MET . 12.6 pt-20 -158.59 128.97 6.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -127.1 154.63 44.47 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -113.32 139.74 48.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.75 42.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 118.387 0.539 . . . . 0.0 111.494 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mp -109.12 127.47 54.2 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -105.49 108.5 25.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -89.37 124.93 34.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 50' ' ' GLU . . . -32.52 115.74 0.1 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.067 1.187 . . . . 0.0 116.067 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.782 ' HB2' HG21 ' A' ' 47' ' ' THR . 82.0 Cg_exo -54.41 159.58 8.08 Favored 'Trans proline' 0 N--CA 1.474 0.359 0 C-N-CA 124.378 3.385 . . . . 0.0 113.487 175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 47' ' ' THR . 45.4 mt-10 -81.52 157.9 24.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.517 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 49.65 35.74 9.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.566 0.746 . . . . 0.0 112.498 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.782 HG21 ' HB2' ' A' ' 44' ' ' PRO . 29.1 p -127.62 171.86 11.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.9 t -99.25 10.1 42.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -106.48 3.94 27.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.274 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 3.5 pt-20 -69.58 156.26 39.19 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 80.7 m-85 79.61 -20.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.192 0.932 . . . . 0.0 110.962 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.9 149.1 39.09 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.117 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 95.44 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -98.38 108.97 50.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.32 -169.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.48 141.44 15.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 73' ' ' PHE . . . -146.44 164.54 32.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.444 0.64 . . . . 0.0 111.716 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.15 136.7 59.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.078 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 120' ' ' LEU . 7.0 mp -118.34 118.55 32.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.902 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 21.8 m -104.39 128.29 52.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.971 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -104.65 135.69 19.28 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 120.933 0.397 . . . . 0.0 110.279 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 70.8 Cg_endo -69.0 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.591 2.86 . . . . 0.0 114.137 -172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.603 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -179.44 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.853 -170.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 66' ' ' LEU . 3.7 m-20 -114.93 29.63 7.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.398 -170.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.9 t80 -58.04 132.79 83.8 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 166.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 16.3 Cg_endo -98.3 91.81 0.14 OUTLIER 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 120.275 1.134 . . . . 0.0 113.414 6.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -170.19 -31.88 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.416 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.1 p -103.45 129.3 25.71 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 23.9 Cg_exo -63.78 124.43 13.6 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.051 2.5 . . . . 0.0 112.647 -174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 66.4 Cg_endo -75.32 169.0 23.4 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.095 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 59' ' ' SER . 21.3 ttmm -108.75 145.53 34.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.0 ttt -149.01 132.28 16.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.947 0.403 . . . . 0.0 111.011 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -147.27 149.65 33.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.644 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 99.1 m-85 -88.31 143.41 27.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 p -85.39 -33.8 21.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.3 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.01 148.31 22.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.54 163.28 16.74 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.094 0.473 . . . . 0.0 110.883 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.429 ' HA ' HD12 ' A' ' 158' ' ' ILE . 20.2 ptp -147.24 170.66 16.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.15 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 140' ' ' ALA . 26.9 t80 -115.5 84.41 2.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.577 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 30.4 t-80 -140.6 131.22 13.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.763 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 11.6 Cg_endo -55.63 -27.61 61.45 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.891 3.06 . . . . 0.0 114.334 -175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.508 HD21 ' HA ' ' A' ' 90' ' ' ILE . 23.9 t-20 -83.57 -6.59 59.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 110.398 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.459 HG12 ' HB3' ' A' ' 79' ' ' HIS . 39.2 mm -97.94 124.96 51.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 122.157 -0.339 . . . . 0.0 110.538 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 m-85 -64.38 154.43 83.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.44 -19.23 65.12 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.787 2.325 . . . . 0.0 111.089 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.9 -0.37 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.121 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.63 -17.34 56.64 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.806 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -57.78 138.55 55.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 111.517 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.07 120.12 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' ILE . 52.5 t -76.78 -39.31 51.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.064 -172.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' HA ' HD21 ' A' ' 81' ' ' ASN . 5.5 pt 8.57 102.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 124.917 1.386 . . . . 0.0 113.587 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 94' ' ' HIS . 25.7 p -64.81 1.83 0.81 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -166.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.1 tt -90.44 -23.15 6.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.751 0.31 . . . . 0.0 110.337 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 119' ' ' ILE . 18.0 mt -84.79 4.26 33.78 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 167.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.609 ' HB2' ' HA ' ' A' ' 91' ' ' SER . 12.8 m170 -120.84 -178.41 3.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.785 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 109' ' ' ARG . . . -153.6 164.44 20.56 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.13 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 1.005 ' HD3' ' HG2' ' A' ' 109' ' ' ARG . 85.6 Cg_exo -49.27 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.088 2.525 . . . . 0.0 113.287 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.69 -37.73 1.87 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.063 178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.7 43.95 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.951 0.882 . . . . 0.0 109.441 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.43 125.98 39.18 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.936 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.35 23.18 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.663 2.242 . . . . 0.0 112.956 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.483 ' HG3' ' HA3' ' A' ' 135' ' ' GLY . 7.9 mmt -153.13 -30.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.81 27.02 57.54 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.222 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' A' ' 91' ' ' SER . 14.6 p90 -72.69 -161.39 0.09 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.432 0.693 . . . . 0.0 111.593 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -53.97 118.84 4.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 111.177 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.7 t -83.47 -14.74 51.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.013 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.2 m -99.44 16.76 22.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.886 0.374 . . . . 0.0 110.975 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.69 46.58 0.56 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.301 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' C ' ' HD2' ' A' ' 109' ' ' ARG . 13.7 mm-40 64.55 117.2 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.615 0.721 . . . . 0.0 112.124 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 1.005 ' HG2' ' HD3' ' A' ' 96' ' ' PRO . 2.3 mpt_? -122.67 176.01 6.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.59 115.01 2.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.945 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 16.1 m -128.01 154.49 78.45 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.945 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.12 -14.63 24.46 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.016 2.477 . . . . 0.0 113.53 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.79 8.7 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.288 0.566 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 111' ' ' SER . 35.6 mm-40 -89.65 157.5 17.99 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.609 -0.682 . . . . 0.0 110.016 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' A' ' 12' ' ' GLU . 16.0 m -143.5 174.05 11.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 ' OE1' ' A' ' 12' ' ' GLU . 35.3 m -64.65 -37.47 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 110.534 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.409 ' HG2' HD23 ' A' ' 121' ' ' LEU . 27.3 tt0 -68.75 -35.98 77.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.132 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HB3' ' H ' ' A' ' 115' ' ' SER . 5.6 tppp? -60.97 -46.88 88.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.088 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 115' ' ' SER . 73.0 mt -60.87 -48.62 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.737 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.644 HD23 HG23 ' A' ' 24' ' ' ILE . 8.9 mp -71.74 -27.91 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.677 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD23 ' HG2' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -68.38 -34.73 76.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.27 0.557 . . . . 0.0 109.648 172.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.3 t -67.17 -31.04 71.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.691 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 126' ' ' MET . 77.7 t -66.61 -46.62 85.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.496 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 120' ' ' LEU . 99.5 t -62.39 -45.82 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.6 p -67.14 -38.38 85.42 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.797 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 17.4 ptt? -64.69 -31.29 72.44 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.652 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 44' ' ' PRO . 89.1 mt -75.15 -23.18 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.933 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' A' ' 47' ' ' THR . . . -91.13 -37.92 13.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.361 . . . . 0.0 110.936 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -120.78 75.64 27.52 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HB2' ' CE2' ' A' ' 144' ' ' TRP . 53.3 Cg_exo -51.45 131.31 36.19 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.024 2.482 . . . . 0.0 113.683 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.58 118.42 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.706 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -144.54 -71.21 0.28 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.682 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -86.16 -60.75 1.92 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.892 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.465 ' H ' ' CD ' ' A' ' 133' ' ' GLU . 32.2 t -71.23 -170.77 0.51 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.823 0.82 . . . . 0.0 112.462 -170.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -177.55 35.48 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -174.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.54 -60.26 4.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.43 -0.885 . . . . 0.0 110.716 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -94.58 93.36 7.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.18 -32.12 49.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.408 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.11 -34.52 63.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.69 -35.62 67.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.023 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 4.1 p -72.56 -32.67 66.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.192 0.52 . . . . 0.0 109.947 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -51.07 52.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.069 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 45.4 tpp -59.81 -32.6 70.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.579 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.602 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 15.1 t-105 -72.79 -46.37 53.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.702 0.287 . . . . 0.0 111.415 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -86.75 -31.77 20.76 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.12 -68.81 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.198 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 150' ' ' GLN . 5.6 t70 -111.76 77.54 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 144' ' ' TRP . 92.3 mtt180 -56.32 -35.17 67.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.855 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.49 -36.06 82.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 111.35 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.572 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.0 OUTLIER -72.23 -31.22 65.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.426 0.632 . . . . 0.0 109.82 178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -65.89 -48.34 71.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.332 0.587 . . . . 0.0 109.774 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -56.4 -42.7 78.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.38 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -67.87 -38.83 83.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 158' ' ' ILE . 70.7 mt -67.61 -35.81 74.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.896 0.379 . . . . 0.0 110.119 175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.05 -45.53 92.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.614 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.77 -33.74 76.56 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.89 -48.2 82.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.294 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 154' ' ' ILE . 49.6 mm -61.13 -37.14 76.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.619 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 155' ' ' ALA . 75.6 t -56.38 -50.64 71.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.152 176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 17.2 mt-30 -62.78 -47.0 85.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.583 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.91 -36.35 84.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.331 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.5 m -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.368 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 159' ' ' VAL . 89.3 mt -77.87 -24.39 48.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.48 0.657 . . . . 0.0 109.712 172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.21 2.33 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.407 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 63.7 mt . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.179 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.67 19.91 10.88 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.767 0.667 . . . . 0.0 112.037 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.5 -38.43 93.44 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.702 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 t -68.37 -23.48 64.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.24 0.52 . . . . 0.0 110.629 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.84 -48.46 24.98 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 6' ' ' LEU . 2.1 tm? -55.77 -48.27 75.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -53.95 -53.92 46.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.021 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 6.0 tpt180 -59.95 -46.59 88.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.713 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.14 -26.7 66.8 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.3 mmt -74.94 -36.12 62.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 110.383 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -62.23 -49.76 74.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.964 171.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 60.1 mm-40 -57.02 -45.7 82.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.354 0.597 . . . . 0.0 110.446 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -49.77 -61.4 2.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.499 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 18' ' ' LEU . 31.6 mtmm -56.6 -36.3 69.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.922 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 12.6 mm-40 -65.21 -40.77 94.58 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.898 0.772 . . . . 0.0 109.53 176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 72.9 mt -69.34 -15.15 63.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.0 m -89.92 -52.79 4.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.069 0.461 . . . . 0.0 110.357 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 14' ' ' LYS . 3.0 mm? -66.44 -43.19 86.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.995 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -139.18 78.37 28.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 89.0 Cg_endo -83.77 113.73 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.692 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 15.1 Cg_endo -63.41 110.3 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.058 1.839 . . . . 0.0 112.426 174.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -54.03 136.64 41.31 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.046 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.94 -16.18 58.68 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.307 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.432 HD11 ' CG2' ' A' ' 124' ' ' VAL . 1.7 mp -115.75 117.75 56.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.91 123.07 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.06 137.66 16.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 119.169 0.895 . . . . 0.0 111.21 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.9 155.42 26.16 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 47.4 Cg_exo -56.09 131.12 43.99 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.446 2.098 . . . . 0.0 112.383 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 24.3 ttt -69.99 92.81 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.535 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 41.8 t30 72.46 103.93 0.07 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 28' ' ' PRO . 51.6 mt-10 -71.47 23.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 7.6 pt-20 -96.01 -36.09 11.16 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.8 t30 -90.64 89.95 7.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.027 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.38 -3.16 55.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.36 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' PHE . 91.1 m-85 -96.2 17.41 15.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.148 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.519 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 14.5 tp10 -157.34 117.81 3.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 14.3 m0 -118.45 148.6 42.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -174.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.2 134.25 55.04 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -139.12 150.48 45.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.464 0.649 . . . . 0.0 111.727 -166.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.82 118.52 34.48 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -101.56 101.06 11.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.2 mtt -82.6 127.07 33.01 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -46.31 141.37 5.69 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.185 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -21.74 -81.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 1 C-N-CA 125.599 4.199 . . . . 0.0 116.465 -170.796 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 32.1 tt0 168.09 -20.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.235 0.47 . . . . 0.0 110.366 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -156.29 51.04 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.956 0.884 . . . . 0.0 108.871 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 73.1 p -140.52 -176.66 4.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.206 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.4 m -82.65 3.3 29.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.708 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.635 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 32.7 m-85 -122.24 -3.32 8.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HA ' ' C ' ' A' ' 43' ' ' GLY . 25.0 tt0 -48.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -170.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -43.88 -19.46 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.97 144.18 31.95 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.283 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.19 99.9 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.94 108.35 59.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.87 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' A' ' 75' ' ' CYS . 71.9 Cg_endo -71.55 141.45 38.23 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.845 2.363 . . . . 0.0 112.275 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.3 161.6 40.64 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.137 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.3 mt -125.82 133.13 69.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.064 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.77 121.71 45.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.761 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 5.0 t -102.74 119.72 39.32 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 35' ' ' PHE . 89.2 m-85 -100.77 131.83 23.01 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' ASP . 78.5 Cg_endo -79.06 154.88 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.056 2.504 . . . . 0.0 112.75 -175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.41 33.72 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.77 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' PRO . 19.9 m-20 -141.41 -5.9 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.879 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 40.7 t80 -56.99 145.94 62.29 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 122.619 0.368 . . . . 0.0 110.317 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.623 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 39.7 Cg_endo -95.28 30.18 14.41 Favored 'Cis proline' 0 C--N 1.345 0.391 0 C-N-CA 124.475 -1.052 . . . . 0.0 112.296 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 97.4 mt -78.46 -36.59 45.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.18 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 63' ' ' ASP . 31.4 p -110.21 149.04 39.56 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.759 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.94 126.7 14.19 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.868 2.379 . . . . 0.0 112.241 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.96 161.09 47.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.678 2.252 . . . . 0.0 112.621 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 77.7 tttt -93.28 147.53 22.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.1 ttt -148.43 130.88 15.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.0 110.872 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 72' ' ' ARG . 26.8 ptt85 -141.8 146.69 36.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.519 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -92.84 137.96 31.91 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.8 p -101.62 1.57 37.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 111.135 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.691 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 42.8 t -101.86 160.87 14.11 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.67 143.35 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 82' ' ' ILE . 41.9 tpp -155.11 159.44 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -147.78 88.92 1.71 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.091 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.523 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 44.2 t-80 -146.14 132.39 9.64 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.759 -174.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.799 ' HB3' ' HB3' ' A' ' 141' ' ' SER . 31.2 Cg_exo -59.27 -34.62 98.04 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.648 2.899 . . . . 0.0 114.412 -171.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -79.39 -10.58 59.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.553 0.692 . . . . 0.0 110.487 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 32.6 mt -99.5 134.55 38.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.166 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 82' ' ' ILE . 69.2 m-85 -70.05 152.87 95.72 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.41 -22.5 71.47 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.262 2.641 . . . . 0.0 112.335 -171.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.61 -3.02 58.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.307 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.99 -25.27 14.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.261 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.27 132.55 53.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.486 0.643 . . . . 0.0 112.391 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 90' ' ' ILE . 2.6 t -86.7 125.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.2 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 46.8 t -77.4 -45.28 26.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.593 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.549 HG12 HG12 ' A' ' 88' ' ' VAL . 8.9 pt 1.75 110.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.599 ' HB3' ' NH1' ' A' ' 109' ' ' ARG . 69.8 m -52.84 -24.58 9.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 8.9 tt -60.24 -45.17 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 120.679 0.276 . . . . 0.0 110.955 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.47 -1.05 56.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 16.6 t-160 -86.09 -80.66 0.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -164.22 150.61 9.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.521 0.201 . . . . 0.0 110.995 -172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.57 -20.31 20.63 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.963 2.442 . . . . 0.0 111.502 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -129.22 63.9 0.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.79 31.56 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 71.16 143.31 0.1 OUTLIER Pre-proline 0 C--O 1.232 0.182 0 O-C-N 123.905 0.753 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.41 72.69 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.91 2.407 . . . . 0.0 112.107 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.4 mmm -83.86 -6.47 59.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.543 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.3 41.85 9.0 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.346 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.906 ' HA ' ' HG3' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -68.55 142.74 55.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.137 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -137.09 -175.63 4.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.651 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m 62.28 -87.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.74 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.518 ' HB3' ' HG2' ' A' ' 108' ' ' GLU . 27.2 m -85.0 -63.77 1.27 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.12 47.08 24.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.315 0.578 . . . . 0.0 110.678 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 106' ' ' SER . 6.3 mm-40 -73.17 140.24 46.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.043 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' NH1' ' HB3' ' A' ' 91' ' ' SER . 2.8 mpt_? -117.43 147.01 43.09 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 76.1 t-105 -57.67 121.6 10.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.608 0.718 . . . . 0.0 111.149 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.508 ' H ' ' HG2' ' A' ' 114' ' ' GLN . 20.9 m -142.93 164.11 34.08 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.67 -6.09 8.37 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.623 2.215 . . . . 0.0 112.994 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 111' ' ' SER . 11.3 p -86.55 -6.68 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.988 0.423 . . . . 0.0 111.408 178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.508 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.7 mm-40 -84.05 146.14 28.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.081 -0.387 . . . . 0.0 110.417 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . 44.7 p -134.11 169.1 17.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.624 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.6 m -70.02 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.444 0.64 . . . . 0.0 109.521 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -61.54 -53.42 56.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.351 174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 114' ' ' GLN . 64.5 tttp -61.83 -40.77 96.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.127 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 115' ' ' SER . 89.5 mt -58.24 -50.89 76.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.345 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 24' ' ' ILE . 11.2 mp -73.13 -27.57 61.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mm? -70.45 -31.23 68.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.199 0.523 . . . . 0.0 110.007 172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.541 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.637 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 70.7 t -63.34 -46.19 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.094 174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 44' ' ' PRO . 72.7 t -58.27 -40.88 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.075 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.9 m -65.27 -41.89 93.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.067 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.6 ptt? -71.21 -31.39 67.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.117 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 93.7 mt -64.67 -30.91 71.93 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.2 0.524 . . . . 0.0 110.807 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.38 -67.99 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.919 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 126' ' ' MET . 35.4 tt0 -101.34 107.02 48.88 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.577 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.05 -174.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.568 2.845 . . . . 0.0 112.646 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.598 ' HB3' ' OE1' ' A' ' 133' ' ' GLU . 6.5 m120 -104.71 95.45 5.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.907 0.86 . . . . 0.0 111.808 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.49 56.98 3.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.934 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.906 ' HG3' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -161.65 -46.49 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.004 0.43 . . . . 0.0 110.393 174.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 p -80.85 -85.45 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.336 0.589 . . . . 0.0 111.584 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 65.03 1.41 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.564 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -51.5 -53.86 33.15 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.28 0.562 . . . . 0.0 109.951 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 82' ' ' ILE . 63.1 t30 -99.63 103.61 15.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.672 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.522 ' HA ' ' OG ' ' A' ' 141' ' ' SER . 58.2 t -67.42 -32.66 58.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.065 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -35.46 78.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.477 0.656 . . . . 0.0 109.505 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.81 -39.44 30.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.856 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.799 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.0 p -74.34 -34.22 63.36 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 110.623 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -66.48 -46.48 76.17 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 150' ' ' GLN . 40.7 tpp -57.95 -32.37 67.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.749 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -81.15 -38.84 26.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 145' ' ' ARG . 2.9 mmp_? -76.05 -35.33 59.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.135 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -149.85 97.97 2.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -55.03 -19.41 6.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.951 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.52 -34.89 18.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.535 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 6.5 mm100 -63.62 -37.79 88.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.854 173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -65.91 -49.06 69.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.122 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -57.07 -39.82 75.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.733 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 153' ' ' LYS . 20.5 ptmt -72.31 -43.01 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.313 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 87.3 mt -67.77 -30.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 0.0 110.062 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.21 -52.31 66.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.189 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 59.1 mttp -66.11 -29.49 69.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.925 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.0 OUTLIER -55.15 -51.96 64.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.0 -34.41 66.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.452 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 155' ' ' ALA . 53.4 t -59.7 -48.88 85.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.91 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.662 ' HB3' HD12 ' A' ' 165' ' ' LEU . 15.6 mt-30 -66.6 -38.02 86.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 68.7 mttm -59.06 -39.31 81.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.482 0.658 . . . . 0.0 109.873 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m -69.03 -35.28 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.378 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.01 0.32 28.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.231 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.67 32.4 8.11 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.678 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 160' ' ' GLN . 29.2 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.384 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.625 0.25 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' HB1' ' HZ ' ' A' ' 35' ' ' PHE . . . -130.94 18.58 5.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.889 0.376 . . . . 0.0 111.36 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.66 71.92 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.85 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -68.14 -33.41 74.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.339 0.59 . . . . 0.0 109.953 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.64 -51.79 52.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.709 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.96 -49.76 74.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.174 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.61 -35.73 74.91 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.571 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 45.4 tpt85 -69.37 -45.84 68.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.0 110.42 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 HD21 ' CE1' ' A' ' 60' ' ' PHE . 65.4 mt -73.14 -24.1 60.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.236 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.7 mmt -70.4 -38.98 74.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.44 -44.95 93.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.175 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' OE2' HG22 ' A' ' 116' ' ' VAL . 9.0 mm-40 -58.35 -46.76 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.175 0.512 . . . . 0.0 110.215 175.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -50.55 -65.81 0.49 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.56 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' O ' HD23 ' A' ' 18' ' ' LEU . 9.5 mtpm? -48.81 -45.73 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.625 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -39.62 78.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.328 0.513 . . . . 0.0 111.438 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.5 mt -63.88 -38.25 90.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.922 0.391 . . . . 0.0 111.203 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.0 m -73.41 -48.3 34.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 14' ' ' LYS . 1.6 mm? -70.56 -40.37 73.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.007 -178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -135.59 82.56 38.88 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.526 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 6.9 Cg_exo -73.17 117.85 5.28 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.94 2.427 . . . . 0.0 111.856 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 11.7 Cg_endo -59.67 150.69 75.07 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.719 2.279 . . . . 0.0 112.232 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.65 146.63 33.95 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 77.21 -23.33 2.26 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.923 -176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 124' ' ' VAL . 1.8 mp -120.08 123.54 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 118.26 1.03 . . . . 0.0 109.998 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 4.5 t -123.94 118.51 54.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.17 137.76 17.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 119.803 1.183 . . . . 0.0 111.533 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.8 170.92 38.48 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.78 119.96 7.54 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.311 2.007 . . . . 0.0 111.095 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.96 -20.78 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.268 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.488 HD22 ' HG3' ' A' ' 32' ' ' GLU . 2.5 p-10 -168.09 134.83 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -59.99 -32.6 71.0 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG3' HD22 ' A' ' 30' ' ' ASN . 0.7 OUTLIER -64.85 -23.87 67.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.005 0.431 . . . . 0.0 111.866 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 36.7 t30 -131.86 107.47 8.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.35 26.22 2.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' HZ ' ' HB1' ' A' ' 2' ' ' ALA . 96.2 m-85 -128.59 13.67 6.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.526 0.679 . . . . 0.0 109.783 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 23.5 tt0 -142.3 115.03 8.6 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 175.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -122.09 148.57 44.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -112.85 146.22 39.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 25' ' ' VAL . . . -138.37 145.84 41.55 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.081 0.467 . . . . 0.0 110.384 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 3.0 mp -109.64 115.72 30.4 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -99.51 98.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.588 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 26.9 mtt -79.67 111.64 16.15 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -44.7 145.12 2.16 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 114.149 -1.387 . . . . 0.0 115.301 -172.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HG3' HG13 ' A' ' 124' ' ' VAL . 73.4 Cg_exo -51.09 133.25 40.75 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.976 3.118 . . . . 0.0 112.435 177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.13 144.12 50.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.2 t70 77.33 31.76 0.47 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.271 1.034 . . . . 0.0 109.238 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 44' ' ' PRO . 34.4 p -132.4 -156.58 0.76 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 152' ' ' TYR . 29.8 t -103.65 -12.0 17.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 119.237 0.926 . . . . 0.0 110.938 172.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 72.9 m-85 -94.82 -1.29 53.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.24 -86.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -46.24 -12.45 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.42 142.06 32.02 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.612 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.48 99.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -100.89 107.93 51.78 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.038 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.62 141.13 21.82 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.765 2.31 . . . . 0.0 111.813 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.01 31.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.197 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.4 mt -125.87 132.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.494 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.61 119.65 40.01 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -98.82 120.96 40.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.913 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.47 ' CE1' HD21 ' A' ' 9' ' ' LEU . 96.2 m-85 -98.76 126.48 38.62 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 121.437 0.637 . . . . 0.0 109.632 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HG2' ' H ' ' A' ' 62' ' ' LEU . 71.9 Cg_endo -69.82 -67.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.609 2.873 . . . . 0.0 113.337 -171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.643 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER 175.34 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.316 -174.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 22.6 m-20 -94.93 16.44 16.09 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.431 -170.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.56 142.71 97.97 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 26.6 Cg_endo -94.64 21.79 30.04 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 124.928 -0.863 . . . . 0.0 113.022 2.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 59.5 mt -77.52 -34.97 53.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 110.034 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.2 m -113.81 142.32 27.58 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.085 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.52 138.68 24.64 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.917 2.411 . . . . 0.0 113.187 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.16 168.58 20.22 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.913 2.408 . . . . 0.0 111.427 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -114.39 170.68 8.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.82 141.61 24.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.911 0.386 . . . . 0.0 111.044 -171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.38 139.71 30.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 132.06 36.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 p -94.83 -2.14 51.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.413 . . . . 0.0 111.562 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.9 t -99.51 -167.59 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -115.65 148.22 39.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.8 ptm -166.97 -167.03 0.88 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.872 0.368 . . . . 0.0 110.684 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE2' ' HE1' ' A' ' 143' ' ' MET . 31.5 t80 -155.49 98.24 1.94 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.675 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.786 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 36.5 t-80 -145.18 130.27 9.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.975 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 26.8 Cg_endo -62.76 -29.09 76.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.61 2.873 . . . . 0.0 114.399 -172.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 132' ' ' ASP . 38.3 t30 -80.05 -10.82 59.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.239 0.542 . . . . 0.0 110.413 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 30.2 mt -101.31 145.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.56 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 89' ' ' CYS . 53.2 m-85 -70.67 146.51 93.7 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 83' ' ' TYR . 34.6 Cg_exo -64.16 -20.42 67.18 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 123.406 2.738 . . . . 0.0 111.516 -176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' OD1' ' HB3' ' A' ' 87' ' ' ARG . 2.9 p30 -82.9 7.85 14.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.88 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.5 -35.1 4.57 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.099 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.544 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 10.0 ttp180 -57.85 138.17 55.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.464 0.649 . . . . 0.0 112.6 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.42 135.57 31.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.06 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.677 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 49.8 t -96.82 -105.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.911 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mt 63.82 127.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 122.022 0.915 . . . . 0.0 110.646 -175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.1 p -60.99 -26.79 67.83 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.48 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 93' ' ' LEU . 7.1 tt -58.4 -45.03 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 110.7 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.532 ' HG ' HG23 ' A' ' 92' ' ' ILE . 96.6 mt -92.42 4.53 53.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 110.983 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -100.27 -66.62 0.9 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 98' ' ' ASP . . . -163.91 138.09 4.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 11.5 Cg_exo -71.34 -33.87 10.54 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.852 2.368 . . . . 0.0 111.835 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -121.38 65.73 0.47 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 16.6 t70 -85.9 154.69 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -175.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 12.0 t70 -74.91 126.3 88.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.108 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 26.7 Cg_exo -62.23 95.51 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.688 2.259 . . . . 0.0 111.849 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.2 mtp -79.39 -44.01 22.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.973 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -159.36 -43.32 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.236 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -77.45 12.08 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 68.19 -171.39 0.19 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.573 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.542 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 8.7 t -84.53 7.22 20.71 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.134 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 19.8 m -67.21 174.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.028 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 106' ' ' SER . . . 75.72 166.79 0.27 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.993 0.808 . . . . 0.0 110.301 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.66 150.25 36.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.32 0.581 . . . . 0.0 111.313 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.627 ' HB3' ' HA ' ' A' ' 96' ' ' PRO . 72.0 mmt-85 -121.09 150.07 41.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -53.84 119.63 5.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.479 0.657 . . . . 0.0 111.824 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.613 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 20.7 m -139.43 156.46 71.59 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.293 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -14.79 8.12 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 123.311 2.674 . . . . 0.0 114.243 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' VAL . 9.2 p -89.89 16.0 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.193 0.521 . . . . 0.0 111.409 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 111' ' ' SER . 27.1 mm-40 -81.61 168.89 17.69 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.671 -0.643 . . . . 0.0 109.635 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 119' ' ' ILE . 48.8 m -170.4 134.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -170.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.46 HG22 ' OE2' ' A' ' 12' ' ' GLU . 33.8 m -56.84 -27.63 26.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 121' ' ' LEU . 32.7 tt0 -66.36 -52.98 41.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.772 176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -60.23 -42.21 94.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 110.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 123' ' ' VAL . 76.4 mt -56.7 -49.24 78.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 124' ' ' VAL . 11.1 mp -72.32 -25.73 61.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.21 -178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mm? -70.47 -35.32 73.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.745 0.307 . . . . 0.0 110.742 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 44.6 p -71.89 -29.72 64.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.729 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.585 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 56.9 t -61.29 -43.08 95.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.616 170.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.532 HG13 ' HG3' ' A' ' 44' ' ' PRO . 71.5 t -63.61 -39.15 84.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.646 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.2 t -60.26 -45.51 93.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.558 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.495 ' CB ' ' HB2' ' A' ' 132' ' ' ASP . 16.5 ptt? -69.13 -29.05 67.02 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 96.7 mt -72.87 -28.3 62.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.757 0.313 . . . . 0.0 111.093 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.39 -24.23 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.39 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -126.75 91.37 47.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.786 ' HA ' ' HE2' ' A' ' 79' ' ' HIS . 54.5 Cg_exo -43.62 -30.09 2.56 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.711 3.607 . . . . 0.0 115.983 -171.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -104.94 78.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.297 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 126' ' ' MET . 38.6 t70 -65.53 -49.12 70.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.433 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.736 ' HG3' ' H ' ' A' ' 134' ' ' SER . 3.6 pt-20 -164.22 -63.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.736 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 88.3 p -80.34 155.71 27.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -169.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -106.88 52.54 0.66 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.04 14.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.951 0.5 . . . . 0.0 111.729 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 40.2 t-20 -95.05 95.19 8.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.55 -37.33 78.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.631 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.56 -32.77 73.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . . . -72.86 -38.06 67.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.761 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -71.93 -32.87 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.498 0.666 . . . . 0.0 109.785 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -67.17 -58.58 4.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.925 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.636 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 42.3 ttp -65.16 -18.49 65.35 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' ' HG2' ' A' ' 130' ' ' PRO . 46.2 t-105 -78.08 -33.67 50.67 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.954 -0.466 . . . . 0.0 110.372 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 36.2 ttp85 -25.37 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.92 1.387 . . . . 0.0 113.096 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -103.4 -22.81 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.668 -0.645 . . . . 0.0 110.929 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -76.29 44.36 0.33 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.836 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -52.46 -34.5 49.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.541 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.65 -36.39 82.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.742 0.306 . . . . 0.0 111.491 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HB3' ' SD ' ' A' ' 143' ' ' MET . 0.9 OUTLIER -68.77 -32.95 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.177 0.513 . . . . 0.0 109.882 177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -68.71 -46.18 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.778 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 48' ' ' CYS . 32.2 m-85 -57.9 -47.51 82.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -65.64 -39.84 91.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 111.486 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.577 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 56.9 mt -68.58 -36.01 72.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.444 175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -62.01 -45.45 93.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.645 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG3' ' SG ' ' A' ' 48' ' ' CYS . 98.0 mttt -63.41 -38.56 91.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -64.35 -41.76 96.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 154' ' ' ILE . 42.8 mm -61.51 -43.11 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.791 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 155' ' ' ALA . 64.5 t -52.76 -61.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.688 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.481 ' CB ' HD12 ' A' ' 165' ' ' LEU . 20.9 pt20 -68.92 -28.84 67.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 0.0 111.476 -175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 157' ' ' GLN . 16.4 mtpp -69.1 -40.73 78.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.965 0.412 . . . . 0.0 110.098 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.4 m -72.09 -24.26 61.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.925 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 163' ' ' LEU . 40.1 mt -84.98 -23.07 28.88 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 64.33 86.4 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.513 -169.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 160' ' ' GLN . 93.9 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.629 -0.701 . . . . 0.0 109.786 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 -160.47 0.31 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.483 0.489 . . . . 0.0 111.04 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.53 -67.15 2.89 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.88 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.787 HG23 ' HE2' ' A' ' 7' ' ' LYS . 99.8 m -65.88 -33.58 76.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.234 0.54 . . . . 0.0 109.581 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 64' ' ' TYR . . . -56.64 -55.05 38.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.878 171.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' MET . 75.4 mt -54.24 -51.48 64.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.22 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.787 ' HE2' HG23 ' A' ' 4' ' ' THR . 62.9 pttt -61.69 -35.79 79.01 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 7.4 tpp180 -68.43 -45.62 72.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.058 175.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' HG ' ' CE2' ' A' ' 64' ' ' TYR . 46.9 mt -61.77 -27.3 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.986 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 23.3 mmt -73.11 -40.76 64.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -44.62 92.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.143 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 38.6 mm-40 -56.91 -47.9 79.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 110.198 174.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -51.39 -63.58 1.09 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.389 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -50.47 -48.25 56.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.885 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -30.74 67.73 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.404 -0.81 . . . . 0.0 111.325 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.04 -6.11 39.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.389 0.614 . . . . 0.0 110.525 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.7 m -97.7 -46.23 6.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.903 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.33 -32.77 66.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.66 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 90.7 m-20 -131.96 98.6 17.32 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 7.8 Cg_endo -87.87 102.75 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.049 2.499 . . . . 0.0 111.45 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 28.5 Cg_endo -65.68 151.73 83.7 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.207 1.938 . . . . 0.0 112.072 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -73.1 147.92 44.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.313 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 42' ' ' MET . . . 75.8 -13.62 6.73 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 114.906 0.723 . . . . 0.0 114.906 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 23' ' ' GLY . 2.1 mp -123.21 124.02 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 119.159 1.48 . . . . 0.0 109.949 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.91 106.55 15.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.24 133.55 20.63 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 121.291 -0.881 . . . . 0.0 111.663 -170.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.46 31.02 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.412 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.08 136.06 33.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.622 2.215 . . . . 0.0 112.598 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 30' ' ' ASN . 23.8 ttt -88.17 103.7 16.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.306 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' MET . 38.4 t30 73.54 116.57 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 124.296 0.998 . . . . 0.0 110.555 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.1 -15.2 1.99 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.71 -52.35 8.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.352 0.596 . . . . 0.0 110.26 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 36' ' ' GLU . 49.8 t30 -91.65 85.87 5.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.729 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.461 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -76.83 -2.42 33.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.767 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -91.25 5.21 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.868 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 36.7 tt0 -132.25 120.32 22.01 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -127.27 153.89 45.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -113.66 145.05 41.9 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -138.46 148.92 44.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.05 0.452 . . . . 0.0 110.65 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 2.6 mp -114.56 118.25 33.2 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.4 96.81 4.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.568 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 33.4 mtt -76.59 117.24 18.03 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.107 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -54.44 129.5 43.88 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.365 -0.834 . . . . 0.0 113.923 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 Cg_exo -43.08 124.46 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 124.01 3.14 . . . . 0.0 112.547 172.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -71.18 150.83 44.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.157 0.504 . . . . 0.0 110.839 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 t70 67.44 26.44 8.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.187 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.643 HG21 ' CB ' ' A' ' 128' ' ' ALA . 3.7 p -132.67 175.64 9.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.268 177.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB3' ' HD1' ' A' ' 152' ' ' TYR . 1.6 p -58.86 -33.07 70.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 66.8 m-85 -103.58 13.67 32.83 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 51' ' ' PHE . 5.6 pt-20 -35.44 -96.89 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.569 ' HB2' HG11 ' A' ' 159' ' ' VAL . 78.1 m-85 -34.47 -20.44 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.82 141.41 36.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.978 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.41 101.48 10.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.38 103.11 33.45 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.971 -170.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 85.9 Cg_endo -78.09 145.49 22.02 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.559 2.173 . . . . 0.0 111.791 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.44 163.8 34.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.2 mt -125.15 135.98 62.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.157 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.68 120.85 40.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.51 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.3 t -107.21 86.42 2.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.184 0.516 . . . . 0.0 109.836 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HA ' ' HB3' ' A' ' 69' ' ' PRO . 88.9 m-85 -60.67 140.49 92.82 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.022 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 69' ' ' PRO . 35.5 Cg_endo -86.15 161.66 10.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.333 2.688 . . . . 0.0 111.919 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.84 -17.16 64.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.879 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 68.6 m-20 -99.72 15.77 25.75 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.769 ' CE2' ' HG ' ' A' ' 9' ' ' LEU . 61.4 t80 -59.22 147.17 76.18 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 169.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 41.4 Cg_endo -94.35 23.83 25.95 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.876 -0.885 . . . . 0.0 111.685 -1.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.3 mt -75.79 -40.52 54.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.139 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 1.6 t -116.58 144.26 32.89 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.701 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 17.2 Cg_exo -67.7 147.41 75.71 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.472 2.781 . . . . 0.0 112.716 -177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.758 ' HB3' ' HA ' ' A' ' 60' ' ' PHE . 59.2 Cg_endo -95.7 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.798 2.999 . . . . 0.0 112.066 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.88 146.28 36.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.447 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.7 ttt -148.11 123.69 10.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.232 0.539 . . . . 0.0 110.323 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 72' ' ' ARG . 5.3 ptp180 -139.57 149.16 43.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.187 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.38 134.97 33.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.224 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -92.69 4.79 53.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 162' ' ' SER . 47.1 t -108.55 -153.63 0.51 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 14.0 pt-20 -127.25 155.89 42.75 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.559 ' HA ' HG21 ' A' ' 158' ' ' ILE . 30.0 ttp -163.9 164.2 23.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.945 0.402 . . . . 0.0 110.531 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -134.28 100.68 4.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.504 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.528 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 51.0 t-80 -149.87 134.4 9.3 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 24.7 Cg_endo -61.25 -31.41 89.51 Favored 'Trans proline' 0 N--CA 1.475 0.408 0 C-N-CA 123.394 2.729 . . . . 0.0 114.157 -171.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -90.56 23.32 3.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.554 0.692 . . . . 0.0 110.275 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.75 142.98 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.456 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.437 ' HB3' ' HD2' ' A' ' 84' ' ' PRO . 45.5 m-85 -78.96 157.63 76.0 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.444 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 83' ' ' TYR . 73.0 Cg_endo -73.51 -15.56 24.67 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.042 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 87' ' ' ARG . 6.5 p-10 -85.34 1.57 47.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.608 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.83 -22.0 42.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.081 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' OD2' ' A' ' 85' ' ' ASP . 16.2 ttm180 -46.93 133.93 10.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.17 119.66 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.509 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 64.1 m -127.24 107.11 9.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.222 0.534 . . . . 0.0 111.395 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.9 pt -143.51 156.94 16.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.308 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p -50.34 -45.43 54.95 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.8 tt -77.29 19.94 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 121.661 0.744 . . . . 0.0 111.032 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 93' ' ' LEU . 7.4 mt -151.59 20.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.282 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -112.05 -63.24 1.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 98' ' ' ASP . . . -163.18 141.59 6.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.908 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HA ' ' HD2' ' A' ' 109' ' ' ARG . 7.1 Cg_exo -74.55 -2.92 13.07 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.266 2.644 . . . . 0.0 111.678 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.4 2.01 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 1.059 ' HB2' ' HB3' ' A' ' 95' ' ' ALA . 33.4 t70 -91.06 150.8 21.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.866 0.365 . . . . 0.0 110.56 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -104.71 116.27 61.25 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.525 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.53 124.44 12.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.383 2.722 . . . . 0.0 112.92 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 64.4 mtm -76.54 -43.2 40.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.96 14.84 0.42 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.505 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.68 154.51 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.316 0.579 . . . . 0.0 112.251 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -143.69 146.85 33.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.294 175.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.6 t 66.72 -75.8 0.05 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.843 0.715 . . . . 0.0 110.99 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.2 m -71.35 93.94 1.18 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.421 0.629 . . . . 0.0 109.983 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -155.61 30.77 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.851 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.86 167.99 19.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.371 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.581 ' HD2' ' HA ' ' A' ' 96' ' ' PRO . 12.9 mmt180 -80.57 160.85 25.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.48 ' O ' ' HB3' ' A' ' 111' ' ' SER . 2.3 p-90 -62.17 -40.89 97.54 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -160.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 1.03 ' HA ' ' HG2' ' A' ' 114' ' ' GLN . 98.6 p 171.72 60.63 0.02 OUTLIER Pre-proline 0 CA--C 1.518 -0.261 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.636 ' HD3' ' H ' ' A' ' 111' ' ' SER . 4.6 Cg_exo -80.62 -55.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.551 0 N-CA-C 108.075 -1.548 . . . . 0.0 108.075 161.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -82.55 -22.92 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.241 170.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 1.03 ' HG2' ' HA ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -83.73 -177.28 6.65 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -175.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.71 154.77 46.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.478 HG22 ' OE1' ' A' ' 12' ' ' GLU . 34.2 m -52.03 -32.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.037 0.381 . . . . 0.0 111.874 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.22 -42.9 92.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.276 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HD3' ' HB3' ' A' ' 114' ' ' GLN . 87.4 tttt -62.03 -41.8 98.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.379 . . . . 0.0 110.367 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 123' ' ' VAL . 77.6 mt -58.36 -53.8 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.394 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' HB3' HG12 ' A' ' 24' ' ' ILE . 11.2 mp -71.51 -33.64 69.38 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.03 -34.49 78.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.364 0.602 . . . . 0.0 110.083 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -64.54 -41.37 96.4 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.537 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.596 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 95.3 t -58.53 -41.31 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.8 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.513 HG13 ' HD3' ' A' ' 44' ' ' PRO . 69.0 t -63.9 -49.44 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.29 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.8 t -57.36 -38.86 74.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.112 0.482 . . . . 0.0 109.992 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.5 ttt -65.12 -36.32 83.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.039 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 94.4 mt -72.51 -30.24 64.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.656 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.643 ' CB ' HG21 ' A' ' 47' ' ' THR . . . -86.01 -32.02 21.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.85 86.27 30.26 Favored Pre-proline 0 N--CA 1.443 -0.789 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.246 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.48 36.02 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.524 2.816 . . . . 0.0 113.683 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -132.0 49.27 2.33 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 133' ' ' GLU . 6.9 m-20 -79.92 -5.13 55.03 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 132' ' ' ASP . 23.3 mm-40 74.51 176.02 0.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.504 -171.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 73.68 144.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.219 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.35 75.77 0.4 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.418 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.81 -29.29 62.6 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.02 0.41 . . . . 0.0 111.033 170.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 56.4 t30 -142.4 99.01 3.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.268 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.25 -30.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.601 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -57.25 -41.38 79.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.587 0.708 . . . . 0.0 109.676 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . . . -78.02 -37.94 45.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.207 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 80' ' ' PRO . 26.5 p -76.49 -37.15 57.26 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.365 0.602 . . . . 0.0 110.264 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.12 -56.54 20.71 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.726 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.447 ' HE3' HD12 ' A' ' 154' ' ' ILE . 46.2 ttp -69.43 -18.07 63.71 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.673 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -76.98 -46.47 23.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.317 0.579 . . . . 0.0 110.287 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -86.51 -20.58 27.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.918 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.03 -72.03 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.553 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -108.88 77.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.582 0.706 . . . . 0.0 110.327 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -55.7 -35.88 66.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.714 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.429 ' HA ' ' HD2' ' A' ' 152' ' ' TYR . 9.1 pt-20 -69.39 -32.32 71.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -65.12 -36.56 84.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.921 0.391 . . . . 0.0 110.577 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -67.35 -45.38 76.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.429 ' HD2' ' HA ' ' A' ' 149' ' ' GLU . 8.6 m-85 -52.48 -49.74 64.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.811 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 154' ' ' ILE . 19.3 ptmt -66.98 -46.15 75.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.576 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.447 HD12 ' HE3' ' A' ' 143' ' ' MET . 70.4 mt -67.88 -32.57 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.778 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.37 -45.18 94.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.039 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 36.7 mttp -68.2 -28.75 67.53 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.629 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 1.8 mp0 -62.9 -43.61 98.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.115 0.483 . . . . 0.0 109.819 174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 77' ' ' MET . 27.9 mm -60.99 -37.42 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.515 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 51' ' ' PHE . 34.1 t -57.14 -47.04 84.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.434 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.9 ' HB3' HD12 ' A' ' 165' ' ' LEU . 61.4 mm-40 -64.86 -41.83 95.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.31 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 69.0 mttm -62.48 -38.74 91.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.922 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 46.8 m -67.06 -31.5 72.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.559 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.44 -26.99 56.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.694 0.759 . . . . 0.0 109.48 173.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 123.07 40.1 0.49 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.355 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.9 HD12 ' HB3' ' A' ' 160' ' ' GLN . 28.4 mt . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.984 -0.531 . . . . 0.0 109.63 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -77.44 -36.29 53.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.95 89.54 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.657 -174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 t -69.98 -26.21 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.284 0.542 . . . . 0.0 109.693 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 64' ' ' TYR . . . -75.13 -45.2 42.49 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 177.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 95.4 mt -55.3 -44.69 75.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.074 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -57.9 -38.06 75.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.267 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.601 ' CG ' ' HD2' ' A' ' 65' ' ' PRO . 41.5 tpt85 -68.14 -44.37 76.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.791 0.329 . . . . 0.0 110.576 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.1 -23.67 58.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 21.1 mmt -69.41 -36.88 77.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.16 94.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.154 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 115' ' ' SER . 8.9 mm-40 -53.85 -50.35 66.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.277 0.56 . . . . 0.0 110.269 174.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -51.52 -65.79 0.5 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.283 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 10' ' ' MET . 28.7 mtpp -49.64 -52.57 29.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.583 -1.19 . . . . 0.0 113.347 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -31.72 71.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.716 0.689 . . . . 0.0 111.278 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 116' ' ' VAL . 32.9 mt -63.2 -35.04 78.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.385 0.612 . . . . 0.0 110.095 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.7 m -69.4 -43.48 73.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.542 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.25 -33.79 65.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -141.94 98.85 6.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 79.8 Cg_endo -85.32 115.43 1.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.637 2.225 . . . . 0.0 112.254 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 20' ' ' PRO . 12.4 Cg_endo -59.46 144.47 99.4 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.636 2.224 . . . . 0.0 112.326 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.09 121.84 14.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.786 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 24' ' ' ILE . . . 76.62 16.4 80.78 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.338 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.471 HD12 ' C ' ' A' ' 23' ' ' GLY . 1.7 mp -125.74 123.5 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.791 0.805 . . . . 0.0 109.974 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 2.9 t -125.76 133.36 69.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.767 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 39' ' ' ALA . . . -152.18 133.05 14.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.899 0.772 . . . . 0.0 110.475 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.7 130.9 6.12 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.854 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.12 144.24 68.48 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.842 2.361 . . . . 0.0 111.688 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 62.9 mtt -81.01 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 32' ' ' GLU . 25.8 p-10 -68.24 131.01 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.18 0.514 . . . . 0.0 110.527 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.31 -5.24 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.677 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 43.0 mt-10 -72.88 -51.91 16.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.506 HD22 ' HG2' ' A' ' 36' ' ' GLU . 6.7 t30 -114.06 86.92 2.51 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.133 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.67 5.13 5.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.992 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 33' ' ' ASN . 67.3 m-85 -89.81 21.6 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.896 -174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 12.1 pt-20 -158.1 132.29 8.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.76 0.791 . . . . 0.0 110.963 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' HD1' ' C ' ' A' ' 36' ' ' GLU . 14.9 m0 -126.58 161.33 28.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.138 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -110.49 135.61 50.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . . . -133.04 142.56 48.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.626 0.648 . . . . 0.0 110.108 -174.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 1.4 mp -97.61 133.75 41.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.628 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.01 96.45 4.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.1 mtt -81.87 123.66 29.02 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -53.36 141.28 31.08 Favored Glycine 0 N--CA 1.449 -0.485 0 O-C-N 123.551 0.532 . . . . 0.0 112.772 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 87.5 Cg_exo -44.82 131.01 10.22 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.468 2.778 . . . . 0.0 113.401 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -9.93 25.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.65 -1.613 . . . . 0.0 112.617 -169.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.24 27.16 4.82 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 122.044 -0.41 . . . . 0.0 110.347 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 128' ' ' ALA . 70.0 p -132.05 -159.87 1.0 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.08 -0.388 . . . . 0.0 110.051 -174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 156' ' ' LYS . 14.7 t -100.51 -11.17 20.36 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 43.0 m-85 -84.06 1.39 44.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.359 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 43.7 tt0 -65.6 154.87 37.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.751 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 75.8 m-85 78.83 -20.62 0.38 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.807 0.843 . . . . 0.0 111.513 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' HA2' HG13 ' A' ' 159' ' ' VAL . . . -76.32 138.46 22.61 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.694 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.6 102.17 11.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -107.02 110.58 63.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.651 -172.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.23 147.01 32.53 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.352 2.035 . . . . 0.0 112.758 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.25 162.81 38.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.205 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.6 mt -127.12 136.4 60.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.356 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.6 mp -121.83 125.92 47.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 t -111.55 134.79 52.88 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.6 153.17 43.04 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.378 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' ' HG3' ' A' ' 65' ' ' PRO . 1.6 Cg_endo -90.23 159.84 4.68 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.474 2.783 . . . . 0.0 113.459 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.59 28.69 0.39 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.145 167.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 8.5 m-20 -103.15 -14.49 16.37 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.153 -173.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.858 ' O ' ' HA ' ' A' ' 5' ' ' ALA . 67.0 t80 160.58 -49.76 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 0 O-C-N 124.84 1.337 . . . . 0.0 114.543 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.688 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 22.9 Cg_exo -53.71 101.98 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.504 0 N-CA-C 118.641 2.516 . . . . 0.0 118.641 -8.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.83 ' N ' ' HB3' ' A' ' 64' ' ' TYR . 16.3 mt -88.82 -24.77 22.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.725 0.774 . . . . 0.0 110.466 163.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -97.8 140.11 21.75 Favored Pre-proline 0 C--N 1.31 -1.114 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.478 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.43 130.36 38.68 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.796 2.331 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 156.2 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.894 2.396 . . . . 0.0 112.513 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' A' ' 70' ' ' LYS . 4.2 ttmp? -94.36 135.04 36.22 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.7 ttt -147.71 140.55 24.83 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.327 0.584 . . . . 0.0 111.46 -170.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 87' ' ' ARG . 10.0 ptm180 -148.6 151.97 35.95 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.058 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -89.75 141.65 28.42 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.8 p -89.11 -38.38 14.38 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.62 -172.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.25 -177.13 5.61 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.213 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -79.05 162.79 25.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.122 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.449 ' HA ' HG21 ' A' ' 158' ' ' ILE . 93.3 mmm -141.59 -36.97 0.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.065 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.3 t80 44.09 83.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.785 -167.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 44.4 t-80 -147.15 130.58 8.19 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.808 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 137' ' ' ASN . 9.7 Cg_endo -53.1 -40.21 77.57 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.185 3.256 . . . . 0.0 113.642 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.553 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 40.3 t30 -86.96 -10.93 52.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.476 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 22.0 mt -97.54 135.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.782 0.325 . . . . 0.0 110.69 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HD2' ' HB2' ' A' ' 87' ' ' ARG . 22.6 m-85 -57.31 144.66 70.09 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.506 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.43 -17.66 26.82 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 C-N-CA 122.988 2.458 . . . . 0.0 111.574 -176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.01 -58.08 7.03 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.21 169.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.58 -8.12 0.85 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.926 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.662 ' HB2' ' HD2' ' A' ' 83' ' ' TYR . 3.6 mtt180 -53.43 -156.93 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.532 0.733 . . . . 0.0 112.75 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 90' ' ' ILE . 13.2 t -102.0 -104.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.643 -0.66 . . . . 0.0 110.081 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 42.0 t 107.95 78.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 110.381 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.672 HG13 HG12 ' A' ' 88' ' ' VAL . 18.5 mt -139.01 148.59 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -20.23 65.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.526 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.997 ' HB ' ' HG2' ' A' ' 108' ' ' GLU . 12.9 tt -73.93 -35.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.228 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.13 9.01 7.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.525 0.679 . . . . 0.0 109.286 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 73.3 m80 -143.39 -149.59 0.28 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.297 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ASP . . . 57.96 55.28 6.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HD2' ' HB3' ' A' ' 98' ' ' ASP . 74.4 Cg_endo -88.66 49.93 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.407 2.071 . . . . 0.0 110.782 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.63 3.02 69.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -169.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.8 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 9.7 t70 -115.49 105.61 13.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.557 -0.821 . . . . 0.0 109.332 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 9.0 p-10 -81.67 120.54 78.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.328 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 53.6 Cg_endo -91.22 115.78 0.45 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.044 2.496 . . . . 0.0 113.093 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 60.56 -172.09 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.352 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.87 43.25 3.15 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.155 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -72.94 146.3 46.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.83 0.348 . . . . 0.0 110.157 175.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.21 18.38 1.38 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.988 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.2 m -80.88 51.55 1.56 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.66 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.9 m 74.12 -23.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.462 0.705 . . . . 0.0 112.132 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 52.64 74.49 0.28 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 111.111 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.997 ' HG2' ' HB ' ' A' ' 92' ' ' ILE . 1.8 pm0 -72.31 160.62 32.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.856 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 95' ' ' ALA . 28.2 tpt180 -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.095 -175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.528 ' CZ3' HD11 ' A' ' 119' ' ' ILE . 52.5 t-105 -64.48 93.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.307 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 113' ' ' VAL . 20.1 m -102.03 164.54 15.6 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.497 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.77 -11.95 4.04 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.554 2.169 . . . . 0.0 113.33 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG12 ' HB2' ' A' ' 111' ' ' SER . 14.4 p -86.17 -10.06 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.061 0.458 . . . . 0.0 110.921 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 111' ' ' SER . 56.2 mm-40 -86.09 148.16 25.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.47 ' HB3' ' OE2' ' A' ' 12' ' ' GLU . 16.8 m -153.59 168.83 24.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG21 HD11 ' A' ' 16' ' ' LEU . 29.6 m -48.15 -40.27 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.93 -42.15 85.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.685 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 115' ' ' SER . 29.6 mmtm -66.71 -47.6 71.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.506 0.193 . . . . 0.0 111.227 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.528 HD11 ' CZ3' ' A' ' 110' ' ' TRP . 72.8 mt -59.33 -49.54 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.778 0.323 . . . . 0.0 111.367 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' HB3' HG12 ' A' ' 24' ' ' ILE . 10.9 mp -67.32 -28.98 68.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.393 -176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.11 -38.34 85.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 110.361 174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.1 m -68.99 -33.9 74.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.144 0.497 . . . . 0.0 109.929 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 76.1 t -62.5 -47.01 94.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.267 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 79.6 t -65.72 -37.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.68 0.276 . . . . 0.0 110.779 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.7 t -58.97 -47.48 84.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.979 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 23.8 ptt? -67.68 -28.34 67.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.809 -0.178 . . . . 0.0 111.285 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 89.6 mt -69.79 -32.93 71.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.192 0.52 . . . . 0.0 110.431 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -76.73 -35.16 57.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.432 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.17 76.57 21.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.626 ' HG2' ' CE2' ' A' ' 144' ' ' TRP . 20.7 Cg_endo -66.01 170.22 12.06 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.17 168.16 28.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.763 ' HA ' ' HB3' ' A' ' 141' ' ' SER . 3.3 p30 -67.67 -8.63 36.51 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.34 114.6 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.8 p -168.19 122.74 0.94 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.569 0.699 . . . . 0.0 112.299 -168.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.74 13.16 32.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.982 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 83' ' ' TYR . . . -123.54 -57.73 1.64 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 42.7 t-20 -136.25 86.95 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.39 . . . . 0.0 111.195 -175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.44 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.067 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.5 -40.38 96.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.233 0.539 . . . . 0.0 110.22 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 80' ' ' PRO . . . -72.07 -33.17 67.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.655 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.763 ' HB3' ' HA ' ' A' ' 132' ' ' ASP . 4.8 m -65.38 -43.02 92.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.401 0.62 . . . . 0.0 109.692 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -59.16 -61.33 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.574 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 62.0 mtm -64.07 -31.2 72.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.626 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 20.9 t-105 -69.25 -46.76 66.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.942 0.401 . . . . 0.0 110.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD3' ' HB3' ' A' ' 132' ' ' ASP . 35.2 ttp180 -73.1 -34.3 66.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.537 0.684 . . . . 0.0 109.99 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.53 -41.2 61.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.509 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -149.29 101.33 3.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.185 0.517 . . . . 0.0 111.163 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -61.69 -13.27 21.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -93.39 -34.95 13.26 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.385 0.612 . . . . 0.0 109.577 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 6.4 tp-100 -59.92 -40.47 88.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.655 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 144' ' ' TRP . 10.6 t80 -71.11 -39.73 71.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.25 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -54.73 -48.05 73.04 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 150' ' ' GLN . 22.6 ptmt -65.23 -40.62 94.31 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.552 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 158' ' ' ILE . 73.5 mt -60.15 -39.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.135 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -59.16 -47.69 84.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.805 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mttt -64.92 -36.19 83.56 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.194 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 154' ' ' ILE . 3.6 tt0 -61.58 -45.18 95.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.62 177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 154' ' ' ILE . 47.2 mm -67.21 -31.39 52.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 110.068 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 155' ' ' ALA . 58.9 t -60.13 -41.36 86.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.155 0.502 . . . . 0.0 109.998 173.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 40.8 mt-30 -64.66 -46.64 81.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.261 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 157' ' ' GLN . 61.6 mttm -62.6 -40.61 97.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 -176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 p -65.98 -31.02 71.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.53 -30.57 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.321 0.581 . . . . 0.0 110.529 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.54 48.86 0.27 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.911 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 32.2 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.729 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 63.5 mtt . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.632 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . -151.39 -54.96 0.14 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.923 0.392 . . . . 0.0 110.498 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' LYS . . . -67.28 -39.42 92.04 Favored Glycine 0 C--O 1.226 -0.393 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.462 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.4 m -70.95 -36.17 72.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 117.851 0.826 . . . . 0.0 110.153 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.32 -46.12 91.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.673 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 2' ' ' ALA . 91.2 mt -56.49 -48.01 78.04 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 173.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 56.8 mttp -56.21 -41.61 75.89 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 11.6 tpt180 -65.01 -40.61 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.148 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 34' ' ' PHE . 87.7 mt -69.51 -23.04 63.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 25.1 mmt -70.11 -37.55 75.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . -66.62 -43.02 85.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.608 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 55.2 mm-40 -58.71 -47.65 83.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.589 0.709 . . . . 0.0 109.761 175.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.85 -60.51 2.68 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.293 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.854 ' HB3' HE21 ' A' ' 15' ' ' GLN . 27.8 tptt -39.32 -55.96 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.355 175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.854 HE21 ' HB3' ' A' ' 14' ' ' LYS . 12.8 mm-40 -63.94 -34.09 77.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.766 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.448 HD12 ' HZ3' ' A' ' 37' ' ' TRP . 42.7 mt -72.69 -16.73 61.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.241 0.543 . . . . 0.0 110.804 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 m -86.46 -43.7 12.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.568 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.59 -46.36 66.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.279 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -130.55 104.78 15.91 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.595 0.236 . . . . 0.0 110.762 -169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 20.9 Cg_endo -93.87 98.44 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.066 2.51 . . . . 0.0 111.16 171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.64 ' HB3' HD21 ' A' ' 121' ' ' LEU . 5.0 Cg_exo -34.9 -82.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.885 3.723 . . . . 0.0 114.784 -173.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 9.4 pt-20 -173.31 112.32 0.21 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.536 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.48 72.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.53 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' LEU . 1.3 mp -123.31 125.28 71.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.372 0.606 . . . . 0.0 109.987 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 40' ' ' LEU . 3.8 t -126.2 109.13 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -142.3 135.86 29.16 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.443 -171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.36 165.73 38.35 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 40.9 Cg_endo -66.81 148.35 82.39 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.48 2.12 . . . . 0.0 111.321 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 41.7 tpp -70.16 -104.74 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.985 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -65.39 125.55 25.46 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.044 171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -62.55 -7.76 5.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.821 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.46 -51.04 12.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.483 0.658 . . . . 0.0 109.511 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -99.03 84.37 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.346 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB2' HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -74.15 2.51 8.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.525 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.04 4.48 41.81 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 11.2 pt-20 -140.74 127.25 20.08 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.809 0.814 . . . . 0.0 110.585 171.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 15.4 m0 -123.19 158.04 31.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ALA . 22.2 tt0 -122.36 143.1 49.86 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' A' ' 55' ' ' PRO . . . -134.55 142.51 47.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.619 0.247 . . . . 0.0 110.433 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 4.4 mp -113.12 117.49 32.11 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HB ' ' HB2' ' A' ' 54' ' ' PHE . 48.5 mm -106.71 73.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 52' ' ' GLY . 35.0 mtt -73.66 54.38 0.47 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -160.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.71 134.57 0.03 OUTLIER Glycine 0 C--N 1.308 -0.982 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.702 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HB2' ' OG1' ' A' ' 47' ' ' THR . 26.3 Cg_exo -61.95 94.46 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.203 1.935 . . . . 0.0 110.321 168.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.772 ' HA ' ' HG3' ' A' ' 50' ' ' GLU . 19.1 tt0 -40.26 14.49 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 44' ' ' PRO . 32.5 t70 -152.81 40.7 0.57 Allowed 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.029 -1.045 . . . . 0.0 110.463 166.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 44' ' ' PRO . 61.3 p -139.07 -169.14 2.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.4 m -81.43 -31.88 32.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.793 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.501 ' HB3' ' HE2' ' A' ' 54' ' ' PHE . 44.5 m-85 -80.32 3.38 21.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.603 176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.772 ' HG3' ' HA ' ' A' ' 45' ' ' GLU . 52.0 tt0 -59.51 145.82 42.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.849 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 30.9 m-85 77.12 -13.1 0.98 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 54' ' ' PHE . . . -76.58 135.83 17.94 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.8 -64.45 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 CA-C-N 117.784 0.792 . . . . 0.0 111.738 -173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.718 ' HB2' ' HB ' ' A' ' 41' ' ' ILE . 20.2 m-30 79.46 68.03 0.17 Allowed Pre-proline 0 C--N 1.292 -1.899 0 C-N-CA 123.844 0.858 . . . . 0.0 109.39 163.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.689 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 50.4 Cg_endo -83.34 143.86 11.33 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.21 2.606 . . . . 0.0 112.233 -177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.8 155.73 44.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.603 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.5 mt -117.26 129.64 73.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 6.9 mp -105.18 121.92 44.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.578 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.5 m -96.57 103.87 15.81 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -89.48 135.4 31.03 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.33 152.47 30.55 Favored 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.133 2.555 . . . . 0.0 112.023 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 1' ' ' MET . 91.6 mt -63.06 -13.61 38.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.744 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 18.2 m-20 -107.4 28.2 8.35 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 173.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 65' ' ' PRO . 43.6 t80 -68.44 143.23 95.22 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.667 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 18.7 Cg_endo -96.25 27.7 17.91 Favored 'Cis proline' 0 CA--C 1.532 0.405 0 C-N-CA 124.739 -0.942 . . . . 0.0 112.987 3.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 31.8 mt -81.19 -35.31 31.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.223 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.3 m -103.46 145.7 31.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.257 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.1 141.29 32.47 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.814 2.343 . . . . 0.0 112.258 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -80.54 152.59 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.325 2.017 . . . . 0.0 112.878 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.28 121.65 42.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.543 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.4 ttt -125.93 137.39 53.71 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.292 -0.255 . . . . 0.0 110.411 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 2.4 ptm180 -144.11 147.69 34.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.816 0.341 . . . . 0.0 111.448 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -88.08 139.14 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.024 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -105.67 8.55 33.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.662 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 18.4 t -99.84 -176.43 3.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.366 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 158' ' ' ILE . 19.5 tt0 -96.07 116.75 29.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.47 ' HG2' ' H ' ' A' ' 78' ' ' PHE . 40.1 ttm -146.83 173.94 11.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.387 0.613 . . . . 0.0 111.473 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' H ' ' HG2' ' A' ' 77' ' ' MET . 61.6 t80 -151.2 99.17 2.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.293 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.658 ' CD2' ' HD2' ' A' ' 80' ' ' PRO . 39.2 t-80 -151.02 135.08 9.43 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.658 ' HD2' ' CD2' ' A' ' 79' ' ' HIS . 18.2 Cg_endo -59.6 -30.86 93.36 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.771 2.981 . . . . 0.0 114.198 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.527 ' HB2' ' CE1' ' A' ' 79' ' ' HIS . 11.4 m120 -78.51 -4.64 49.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.98 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 83' ' ' TYR . 24.3 mt -102.43 125.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.015 0.436 . . . . 0.0 111.253 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 82' ' ' ILE . 24.2 m-85 -65.62 169.57 6.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.773 173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.34 -28.86 63.33 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.048 1.832 . . . . 0.0 110.524 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.93 -6.02 48.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.611 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.2 -7.52 81.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.917 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HE ' ' HB2' ' A' ' 87' ' ' ARG . 17.1 ttm180 -56.42 134.47 53.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.04 122.53 37.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.839 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.545 ' HA ' ' HE1' ' A' ' 94' ' ' HIS . 51.1 t -108.33 94.48 5.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.843 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 pt -140.98 148.31 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -46.09 -43.75 14.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.617 HD11 ' HB3' ' A' ' 114' ' ' GLN . 7.2 tt -80.02 -23.43 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -172.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 mt -80.69 3.94 20.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.97 0.89 . . . . 0.0 108.882 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.795 ' HB3' HH21 ' A' ' 109' ' ' ARG . 64.6 m80 -119.61 165.42 14.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.252 176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 96' ' ' PRO . . . -150.7 168.51 10.88 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.19 -172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 35.1 Cg_endo -65.51 53.55 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.905 2.404 . . . . 0.0 112.372 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -155.44 20.95 0.55 Allowed Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -113.93 175.07 5.63 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 26.1 t70 -93.23 123.97 59.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 24.6 Cg_exo -64.53 83.14 0.16 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.956 2.438 . . . . 0.0 112.157 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.1 mtm -79.88 -40.92 27.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.023 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -156.2 1.75 0.15 Allowed Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.361 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -79.35 -167.42 1.19 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.335 0.254 . . . . 0.0 110.878 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.2 60.26 2.73 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.09 0.948 . . . . 0.0 109.497 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.1 t -154.64 49.48 0.6 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.553 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.1 m 67.94 77.29 0.25 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.838 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -158.92 121.29 3.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.132 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.84 150.08 39.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.795 HH21 ' HB3' ' A' ' 94' ' ' HIS . 32.2 mmm-85 -117.45 178.17 4.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.301 -175.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 77.0 t-105 -57.39 116.29 3.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.428 0.633 . . . . 0.0 110.935 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.6 m -133.7 157.21 78.44 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.07 -9.25 7.63 Favored 'Trans proline' 0 N--CA 1.476 0.46 0 C-N-CA 122.937 2.424 . . . . 0.0 113.896 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.54 -2.09 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.531 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.617 ' HB3' HD11 ' A' ' 92' ' ' ILE . 35.9 mm-40 -86.77 156.07 20.07 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.6 m -150.05 154.95 39.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.284 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 119' ' ' ILE . 30.9 m -46.56 -41.56 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.09 -46.34 87.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.674 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.3 -36.83 84.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.4 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 116' ' ' VAL . 74.2 mt -59.94 -49.1 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' VAL . 10.1 mp -70.49 -26.67 63.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 21' ' ' PRO . 3.3 mm? -67.3 -33.14 74.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.103 0.478 . . . . 0.0 110.346 173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.7 t -69.2 -33.8 73.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 81.5 t -66.0 -45.13 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.382 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 120' ' ' LEU . 61.5 t -62.17 -38.27 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.7 t -66.06 -43.25 87.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.119 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 123' ' ' VAL . 21.4 ptt? -69.73 -26.65 64.42 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.053 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 87.0 mt -76.54 -26.0 54.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.198 0.523 . . . . 0.0 110.504 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 47' ' ' THR . . . -74.25 -29.41 61.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 109.61 175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -171.48 120.92 0.48 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.176 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 97.7 Cg_exo -42.29 117.22 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.817 2.345 . . . . 0.0 110.795 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 0.6 OUTLIER -78.53 -8.83 58.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -164.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 131' ' ' ASN . 20.2 t70 79.4 -15.37 0.77 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.59 0.556 . . . . 0.0 111.293 173.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -76.64 74.39 3.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.491 ' HB3' ' ND2' ' A' ' 81' ' ' ASN . 25.4 p -176.21 174.03 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.71 57.63 0.28 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 166.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.08 -71.44 0.75 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.233 -0.483 . . . . 0.0 110.84 -166.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' HA ' ' A' ' 80' ' ' PRO . 51.8 t-20 -99.87 101.34 12.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.662 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.1 t -59.79 -38.86 78.0 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.763 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.596 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 29.1 t70 -67.89 -39.13 83.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.135 0.493 . . . . 0.0 109.973 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.06 62.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.66 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -67.68 -44.75 77.04 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 109.889 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 30.5 ttpt -56.01 -50.32 71.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.144 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 45.2 ttm -61.72 -40.38 94.86 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.712 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CG ' ' HG2' ' A' ' 130' ' ' PRO . 26.4 t-105 -61.3 -44.28 97.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 0.0 111.358 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.6 mtt-85 -83.28 -33.54 25.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.504 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.13 -56.67 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 111.329 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -124.54 71.57 1.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.388 0.613 . . . . 0.0 109.922 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -60.16 -28.04 67.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.988 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.55 -32.43 74.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -70.79 -39.39 73.18 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -61.53 -47.03 87.44 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.0 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -54.92 -50.6 68.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.274 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -67.78 -41.81 82.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.738 0.304 . . . . 0.0 111.533 -176.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.619 ' O ' ' HG2' ' A' ' 157' ' ' GLN . 65.0 mt -64.07 -37.08 78.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.02 0.438 . . . . 0.0 109.993 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 159' ' ' VAL . . . -60.08 -45.01 94.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.796 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.57 ' O ' ' HB ' ' A' ' 159' ' ' VAL . 62.9 mttm -67.57 -34.44 77.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.399 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 154' ' ' ILE . 0.3 OUTLIER -71.03 -35.51 72.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 76' ' ' GLU . 23.1 mm -61.39 -36.01 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 121.246 0.546 . . . . 0.0 110.161 173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 156' ' ' LYS . 44.2 t -56.92 -51.54 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.527 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 53.6 mt-30 -64.43 -40.24 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.429 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HD3' ' OE1' ' A' ' 76' ' ' GLU . 67.5 mttm -65.06 -36.68 85.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.4 m -65.36 -27.65 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.672 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.46 -28.02 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.667 0.746 . . . . 0.0 109.932 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 111.32 34.44 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.195 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 51.3 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.05 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.476 0.179 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.88 -173.44 1.15 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.84 -66.96 3.75 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.368 174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 7' ' ' LYS . 9.0 t -63.54 -30.56 71.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.908 0.385 . . . . 0.0 110.7 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -48.07 64.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' O ' ' HG3' ' A' ' 10' ' ' MET . 88.4 mt -59.22 -56.53 20.99 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.034 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 4' ' ' THR . 55.6 pttt -53.43 -38.66 63.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 65' ' ' PRO . 8.0 tpt180 -74.54 -42.43 58.83 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.049 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.27 -29.28 68.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 6' ' ' LEU . 38.6 mtt -67.32 -39.59 85.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -46.93 79.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.551 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 8' ' ' ARG . 19.3 mm-40 -54.74 -46.51 74.28 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.283 0.564 . . . . 0.0 109.758 176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -53.43 -62.56 1.58 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.71 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -53.4 -44.81 68.98 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.414 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.21 -32.29 73.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.276 0.944 . . . . 0.0 110.941 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 45.2 mt -72.59 -0.02 11.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.916 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 m -105.18 -44.11 4.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.574 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.06 -46.68 76.9 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.904 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -138.2 73.84 43.46 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . 70.8 Cg_endo -78.94 117.23 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.408 2.072 . . . . 0.0 112.26 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' HG13 ' A' ' 24' ' ' ILE . 2.4 Cg_endo -43.45 134.48 6.81 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.376 2.717 . . . . 0.0 112.076 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.66 142.44 51.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.466 0.65 . . . . 0.0 111.078 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.17 71.49 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.464 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 ' HB2' ' A' ' 21' ' ' PRO . 42.0 mm -120.65 120.5 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.51 115.63 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.32 136.12 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.129 0.877 . . . . 0.0 111.385 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -162.41 160.34 32.58 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 53.9 Cg_exo -52.29 132.57 44.74 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.576 2.184 . . . . 0.0 111.831 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG3' ' OE1' ' A' ' 38' ' ' GLU . 55.3 ttp -50.16 -26.98 5.1 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.762 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.59 ' ND2' ' HG2' ' A' ' 32' ' ' GLU . 33.9 t30 -165.8 136.59 3.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.16 -12.44 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -165.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HG2' ' ND2' ' A' ' 30' ' ' ASN . 9.6 pt-20 -82.56 -44.4 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.505 0.669 . . . . 0.0 109.782 175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 59.8 t-20 -86.5 97.39 10.46 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.127 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 -5.2 56.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -92.56 0.73 57.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 0.0 110.437 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -137.69 126.24 23.58 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.777 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 19.5 m0 -122.12 153.27 38.93 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 57' ' ' ILE . 23.3 mt-10 -121.6 146.64 46.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 171.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -141.6 151.04 42.79 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.284 0.564 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.99 119.21 38.46 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.42 97.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.1 mmt -76.9 122.07 24.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.918 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 49' ' ' PHE . . . -56.43 135.17 50.61 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.556 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 47' ' ' THR . 32.8 Cg_exo -61.19 136.7 66.33 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.62 2.88 . . . . 0.0 112.654 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -59.72 138.59 57.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.353 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 t0 62.98 34.18 14.23 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.097 0.959 . . . . 0.0 111.647 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 44' ' ' PRO . 20.5 p -129.94 173.09 11.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.018 -0.426 . . . . 0.0 110.365 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 156' ' ' LYS . 0.8 OUTLIER -56.4 -43.26 79.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.554 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 88.2 m-85 -89.61 13.17 14.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.756 -175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 51' ' ' PHE . 29.8 tt0 -53.95 137.4 39.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 13.7 m-85 80.88 -6.99 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.185 0.928 . . . . 0.0 111.974 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 159' ' ' VAL . . . -76.71 151.79 39.95 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.875 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.65 95.26 2.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -103.28 113.96 65.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.113 -171.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.69 141.46 24.75 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.506 2.137 . . . . 0.0 111.8 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.24 162.5 38.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.737 HG12 ' HG2' ' A' ' 38' ' ' GLU . 61.3 mt -124.85 131.07 73.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.399 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.1 122.4 47.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.578 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.7 t -105.06 122.79 46.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.496 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 69' ' ' PRO . 97.6 m-85 -102.16 136.42 19.45 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.307 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' ASP . 60.0 Cg_endo -80.0 158.28 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.012 2.475 . . . . 0.0 111.824 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 1' ' ' MET . 89.0 mt -72.93 32.33 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.5 m-20 -148.59 10.07 0.83 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.99 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 68' ' ' PRO . 27.4 t80 -66.85 145.48 98.93 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.68 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 57.1 Cg_endo -96.05 26.1 20.65 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.84 -0.9 . . . . 0.0 113.065 0.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 84.9 mt -66.61 -27.09 67.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.083 0.944 . . . . 0.0 109.65 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.443 ' HB2' ' HZ2' ' A' ' 110' ' ' TRP . 30.1 p -139.45 119.81 9.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.757 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.646 ' HG2' ' CD2' ' A' ' 110' ' ' TRP . 1.9 Cg_endo -46.16 178.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 124.067 3.178 . . . . 0.0 113.829 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 36.7 Cg_endo -84.53 -176.92 2.7 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.383 2.055 . . . . 0.0 113.092 -176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 2.9 tppp? -121.26 163.6 18.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -149.98 146.78 27.21 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.169 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' ARG . 9.0 ptm180 -144.87 152.16 39.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.565 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -94.32 140.5 29.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -85.71 -36.21 20.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 19.2 t -76.51 -153.26 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.826 0.346 . . . . 0.0 110.21 172.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.12 166.41 12.05 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.425 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 49.4 ttm -166.66 171.65 11.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.398 0.618 . . . . 0.0 110.99 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 77' ' ' MET . 24.0 t80 -145.56 94.62 2.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.967 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.594 ' NE2' ' HA ' ' A' ' 130' ' ' PRO . 54.5 t-80 -156.77 138.93 10.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.744 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.445 ' CB ' ' HB3' ' A' ' 141' ' ' SER . 69.3 Cg_endo -73.87 46.49 1.3 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.195 2.597 . . . . 0.0 113.722 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.621 ' OD1' HG12 ' A' ' 90' ' ' ILE . 24.0 t-20 -154.16 8.41 0.34 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.392 0.615 . . . . 0.0 109.526 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.469 HG22 ' HA2' ' A' ' 86' ' ' GLY . 32.5 mm -91.31 -108.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 O-C-N 121.49 -0.756 . . . . 0.0 111.676 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.573 ' HD2' ' HB3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER 160.1 159.25 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 126.124 1.77 . . . . 0.0 108.171 -173.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.28 -33.66 29.79 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 121.902 1.735 . . . . 0.0 110.165 175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.83 -1.53 52.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.814 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' HA2' HG22 ' A' ' 82' ' ' ILE . . . 73.65 -0.51 49.82 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.391 -176.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 19.5 tpt180 -69.59 45.9 0.07 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 72' ' ' ARG . 39.8 t 29.39 110.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.02 86.01 2.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.142 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.621 HG12 ' OD1' ' A' ' 81' ' ' ASN . 4.7 mt -104.88 154.4 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 6.7 p -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.163 0.506 . . . . 0.0 110.216 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.689 HD11 ' HB3' ' A' ' 114' ' ' GLN . 6.4 tt -68.75 -38.2 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.947 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.555 HD21 HD13 ' A' ' 119' ' ' ILE . 16.6 mt -82.81 27.92 0.51 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 110' ' ' TRP . 46.4 t-80 102.62 87.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 124.873 1.358 . . . . 0.0 111.001 165.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -150.9 56.41 2.05 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.057 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 95' ' ' ALA . 6.3 Cg_exo -79.54 -60.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.507 2.138 . . . . 0.0 111.25 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.99 35.82 2.65 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -90.41 121.17 32.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.484 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 11.4 t70 69.98 138.8 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.112 0.883 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 99' ' ' ASP . 17.1 Cg_exo -67.27 79.53 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.054 2.502 . . . . 0.0 112.94 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.519 ' SD ' ' HE2' ' A' ' 103' ' ' TYR . 65.3 mtm -148.42 -178.09 6.12 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -157.56 56.78 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.563 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HE2' ' SD ' ' A' ' 101' ' ' MET . 65.9 m-85 -71.22 153.4 42.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.979 0.419 . . . . 0.0 111.383 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.01 115.08 0.97 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.743 171.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 t -156.27 67.91 0.6 Allowed 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.3 t 68.77 27.71 5.7 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.899 -171.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.73 103.92 7.96 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.061 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.41 166.82 22.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.216 0.531 . . . . 0.0 111.039 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -118.51 153.51 34.07 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.817 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.646 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 36.8 t-105 -56.4 111.49 1.0 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.707 1.203 . . . . 0.0 112.434 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 53.7 m -125.62 156.68 70.44 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -52.52 -21.08 13.29 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.392 2.062 . . . . 0.0 112.337 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 113' ' ' VAL . 96.3 t -111.57 68.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.448 0.642 . . . . 0.0 110.53 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.689 ' HB3' HD11 ' A' ' 92' ' ' ILE . 33.1 mm-40 -105.64 -12.47 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.874 -0.516 . . . . 0.0 111.993 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' HG13 ' A' ' 119' ' ' ILE . 25.4 m 55.81 148.72 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' O ' HD13 ' A' ' 120' ' ' LEU . 20.5 m -75.88 -38.84 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 O-C-N 121.493 -0.754 . . . . 0.0 109.73 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -64.57 -42.61 95.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.471 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HB3' ' O ' ' A' ' 114' ' ' GLN . 80.1 tttt -60.55 -45.6 93.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.405 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.555 HD13 HD21 ' A' ' 93' ' ' LEU . 75.9 mt -63.49 -41.07 91.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.971 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 24' ' ' ILE . 4.5 mp -58.82 -46.2 88.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.251 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 121' ' ' LEU . 4.2 mm? -66.84 -29.43 69.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.933 0.397 . . . . 0.0 110.698 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 t -68.1 -36.07 79.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.187 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 119' ' ' ILE . 97.0 t -67.99 -39.49 81.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 0.0 110.106 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 24' ' ' ILE . 87.6 t -62.26 -41.2 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t -61.98 -37.27 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 4.8 ttt -69.13 -38.93 79.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.281 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 123' ' ' VAL . 85.1 mt -77.79 -30.69 51.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.313 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 47' ' ' THR . . . -67.07 -31.48 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 110.846 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -161.96 125.48 1.88 Allowed Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.319 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HA ' ' NE2' ' A' ' 79' ' ' HIS . 52.0 Cg_exo -52.92 107.15 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.661 2.241 . . . . 0.0 111.701 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.7 169.71 17.11 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.494 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 55.96 61.15 2.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.236 0.96 . . . . 0.0 109.882 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -74.34 68.16 1.49 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.484 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.419 ' O ' ' HE3' ' A' ' 101' ' ' MET . 78.9 p -63.51 -7.33 6.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' ' CE ' ' A' ' 101' ' ' MET . . . 99.22 48.73 1.67 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.818 -1.182 . . . . 0.0 112.364 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.93 -24.87 9.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.041 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -151.74 94.04 1.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.956 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.78 -36.45 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.065 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.9 -34.51 78.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.276 0.56 . . . . 0.0 109.935 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.77 -43.1 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.344 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.445 ' HB3' ' CB ' ' A' ' 80' ' ' PRO . 8.7 p -73.59 -41.96 62.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.298 0.571 . . . . 0.0 110.889 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -63.06 -53.33 55.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.413 ' HB3' ' HE2' ' A' ' 143' ' ' MET . 45.8 ttp -64.69 -34.49 78.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.504 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -58.71 -46.5 87.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 110.927 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -74.73 -30.03 61.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.67 -52.7 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.821 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -135.57 91.09 2.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.236 0.541 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.1 ptt180 -48.31 -40.82 26.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.938 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -63.64 -38.21 90.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.512 -177.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.442 HE21 ' CA ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -64.0 -39.11 93.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.521 177.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HZ ' ' HA ' ' A' ' 79' ' ' HIS . 47.1 t80 -69.34 -48.16 62.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.837 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 9.4 m-85 -50.59 -54.24 24.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -43.23 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.858 -174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -70.57 -31.91 47.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.809 0.338 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.81 -44.11 70.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.485 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 152' ' ' TYR . 27.4 mtpp -69.54 -26.43 64.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -59.77 -44.57 93.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 77' ' ' MET . 28.8 mm -59.57 -38.55 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.67 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 52' ' ' GLY . 47.1 t -54.39 -56.8 8.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 165' ' ' LEU . 20.0 pt20 -70.52 -28.34 64.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.303 -177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -68.48 -34.46 75.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.698 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.3 m -65.17 -32.11 73.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.62 175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.5 mt -77.56 -31.0 52.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.667 0.746 . . . . 0.0 110.1 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.94 37.71 2.48 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.47 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 160' ' ' GLN . 70.9 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.351 178.822 . . . . . . . . 1 1 . 1 stop_ save_